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Over the past two decades, gold nanoparticles (AuNPs) have emerged as 
promising tools for biomedical applications. Their unique optical properties enable 
sensitive detection and effective treatment strategies. Additionally, the expanding toolkit 
of AuNP colloidal synthesis, combined with their straightforward surface 
functionalization, allowing for their conjugation with a variety of targeting and / or 
therapeutic ligands, contribute to their increasing use. This thesis explores the effects of 
nanoparticle size, shape, composition, and surface chemistry in the design and application 
of AuNPs for biological imaging and cancer treatment applications. 
The 1
st
 chapter introduces various AuNP synthesis, characterization, and 
conjugation strategies, and presents an overview of their tunable optical properties. 
Recent AuNP applications such as biological imaging, diagnostics, and cancer treatments 
(Chapter 1) are reviewed to prepare the reader for the remaining chapters. Then, 
Chapter 2 discusses the effect of varying surface chemistries on nanoparticle localization 
within living cells. Using different targeting ligands, a dynamic profile of AuNP 
localization was obtained. Cellular localization was found to critically affect AuNP 
scattering properties, a crucial component of biological imaging. Increased subcellular 
targeting was found to result in greater and more rapid localization, resulting in increased 
light scattering and enhanced imaging (Chapter 2). Subsequently, the nuclear-targeted 
AuNPs (NT-AuNPs) previously found to give the greatest imaging enhancement were 
employed as probes to increase the inherent light scattering from cells. Chapter 3 
describes a technique to use these NT-AuNPs to compare the relative efficacies of three 
xxvi 
 
clinically relevant chemotherapeutic drugs. This allows the use of a single sample of cells 
in real-time using inexpensive lab equipment, saving time and material costs while 
imparting the potential to rapidly screen drugs or analogs to determine the most effective 
option. 
The remainder of this thesis focuses on plasmonic photothermal therapy (PPT), an 
emerging treatment where AuNPs convert light into heat, causing cell death specifically 
in the vicinity of the targeted AuNPs. Chapter 4 discusses the use of NT-AuNPs to 
induce PPT cell death while simultaneously serving as scattering probes to monitor the 
associated molecular changes through time-dependent surface-enhanced Raman 
spectroscopy of single cells. The same molecular changes were observed using different 
AuNP sizes, concentrations, and laser intensities, indicating the consistency mechanism 
of action of PPT. Finally, the use of platinum-coated gold nanorods (PtAuNRs) is 
introduced in Chapter 5 to mitigate the side effects of PPT. Platinum, commonly used 
for oxygen reduction in catalysis, is incorporated to scavenge reactive oxygen species 
(ROS), allowing the decoupling of thermal and chemical effects during PPT. The 
PtAuNRs protected untreated cells from the ROS byproducts of PPT, making them ideal 
candidates to advance the treatment while reducing deleterious side effects. This thesis 
presents a fundamental investigation of the influence of AuNP properties on imaging and 
cancer treatment, which can be used to continue advancing their utility and applications. 
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CHAPTER 1. INTRODUCTION [1] 
 (This chapter was published in Aioub, M.; Austin, L. A.; El-Sayed, M. A., Gold 
Nanoparticles for Cancer Diagnostics, Spectroscopic Imaging, Drug Delivery, and 
Plasmonic Photothermal Therapy. In Inorganic Frameworks as Smart Nanomedicines, 
Vol. 7, Grumezescu, A. M., Copyright Elsevier (2017).) 
As a noble metal, gold has been highly valued for over 5000 years due its 
scarcity, malleability, and stability, being easy to work but remaining inert under most 
conditions. In particular, the use of colloidal gold, or gold nanoparticles (AuNPs) 
dispersed in a solution or medium, also dates back over thousand years. It was first used 
as an additive to color glass or ceramics and later to treat various diseases in the Middle 
Ages. One of the earliest and most famous examples of the use of colloidal gold is the 
Roman Lycurgus cup dating back to the 4
th
 century. The cup appears red when light is 
viewed transmitted through the cup, or green when the reflected light is observed.
2-3
 
While the presence of AuNPs may not have been known or understood in these early 
times, the first scientific report of the synthesis and optical properties of colloidal gold is 
generally attributed to Michael Faraday, who reported the synthesis of red solutions of 
colloidal gold through a two-phase approach. He then created thin films of AuNPs and 
observed the color change of the films at different interparticle separation distances by 
mechanically compressing the films.
4
 These represent some of the first investigations into 
the optical properties of AuNPs. 
More recently, the advent of the electron microscope, enabling the direct 
observation of nanomaterials, and a growing understanding of the electronic and 
chemical properties of materials on the nanoscale has led to the emergence of many new 
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fields of study. In particular, AuNPs have served a key role in the emergence of 
nanotechnology for biological, medical, and pharmaceutical applications over the last 20-
30 years.
5-14
 Some of the most common uses of AuNPs include as diagnostic probes, 
allowing for enhanced spectroscopic signals for the detection of biological processes.
10
 
AuNPs have also historically been used as imaging tags in electron microscopy due to the 
high contrast afforded by the strong scattering gold lattice (for immunostaining),
15-16
 and 
as probes for cellular
8, 17
 or photoacoustic imaging.
6, 17
 Additionally, assays using AuNPs 
as colorimetric, fluorometric, or electrochemical sensors are used daily for applications 
ranging from pregnancy tests to the detection of biological threats.
18-20
 Furthermore, the 
small size of nanomaterials has led to their widespread use as drug delivery vehicles, 
capable of releasing high local drug payloads.
21-22
 Recently, combined therapeutic 
treatments utilizing multiple AuNP properties, such as plasmonic photothermal therapy 
(PPT) where the nanoparticles convert light to heat into induce hyperthermia, or 
photodynamic therapy, which often combines the AuNP photothermal properties with 
their drug delivery capabilities, have emerged.
17-18
 Table 1.1 below outlines some AuNP 
properties and several of their common biomedical applications. 
 











Biocompatibility X X X X X X 
Surface 
Modification 
X X X X X X 
Stability X X X X X X 
Absorption  X   X  
Scattering X  X   X 
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The range of applications for AuNPs has been aided by the expanding 
methodology for the wet-chemical synthesis of various nanoparticle sizes and shapes, as 
well as increasing techniques for their biochemical conjugation and surface 
modifications.
22-23
 This chapter will discuss the synthesis, characterization, and 
modification of AuNPs. Their optical properties and some emerging biomedical 
applications in cellular and spectroscopic imaging, diagnostics, and cancer treatment will 
also be discussed. 
1.1 Gold Nanoparticle (AuNP) Synthesis, Conjugation, Characterization 
1.1.1 Synthesis 
The desire for well-defined AuNP shapes and sizes has led to significant interest 
in various synthetic techniques, including wet-chemical or colloidal synthesis, 
electrochemical techniques, photolithography and electron beam lithography. 
Lithographic techniques serve as excellent methods for the production of 2 dimensional 
arrays through the vapor deposition of gold onto a prefabricated support, followed by 
chemical etching of the support matrix. Large arrays of nanostructures can be obtained 
with precise control over the AuNP geometry, size, and interparticle separation 
distances
10, 18
. However, these methods are time consuming and generally not amenable 
for in vivo or in vitro biological applications due to the extra steps required for washing 
the AuNPs and transferring them from the solid substrate into a biocompatible solution 
for their functionalization and application. 
Among the traditional AuNP synthetic strategies, the reduction of gold (III) salts 
remains the most popular due to its scalability for producing large amounts of material, 
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ease of tuning the nanoparticle size, shape, and surface chemistry, and the relative 
monodispersity of the synthesized AuNPs. The first structural study of AuNP synthesis 
was reported by Turkevich et al. in 1951, using various synthetic conditions including 
altering ascorbic acid and sodium citrate concentrations to reduce the gold salt, and using 
UV irradiation.
25
 Subsequently, Frens performed a systematic study of Turkevich’s 
citrate reduction method to improve the procedure, yielding spherical AuNPs with 
diameters of ~ 10 – 150 nm
26
 (Figure 1.1A), although in practice, size and shape control 
suffer for particle diameters larger than ~50 nm. 
While these approaches are still the most commonly used techniques for spherical 
AuNP synthesis, numerous other methods and modifications have been introduced in 
recent years, including the reverse addition method,
27
 the Brust-Schiffrin method,
28
 
biological approaches using plant extracts or enzymes,
29
 and seeded growth methods.
30-31
 
As implied by the name, the reverse addition method reverses the traditional citrate 
reduction technique by adding the gold salt into a citrate solution while heating (instead 
of adding citrate to reduce a hot solution of aqueous gold salt), resulting in monodisperse 
gold nanospheres with 5 – 10 nm diameters.
27
 These smaller AuNPs possess the desirable 
attributes of those synthesized using the standard citrate reduction technique, namely 
biocompatibility and ease of surface modification. They are also capable of passing 
through the nuclear pore complex which has a diameter of ~ 10 nm but can expand to a 
maximum of ~38 nm.
32
 This size regime allows for the targeting of cell nuclei for drug or 
gene delivery applications as well as their use as seeds
33
 for further AuNP growth. The 
Brust-Schiffrin method allows for the formation of even smaller AuNPs of 1.5 – 5.2 nm 




 Although the biological syntheses of AuNPs are an 
emerging field, existing methods do not exhibit the same size control or surface 
functionality as the citrate reduction technique and are therefore not widely used.
29
 
For the synthesis of larger nanospheres, desirable for imaging applications, seed 
mediated approaches are commonly used and fall into two general categories, kinetically 
controlled growth or chemically controlled growth. Under kinetically controlled growth 
conditions, seeds are formed using the standard citrate reduction technique. The reaction 
solution is then cooled below 90°C and excess gold and citrate are added. At that 
temperature, the citrate cannot reduce the gold salt to form new particles so the gold ions 
deposit onto the existing seeds, forming larger, spherical AuNPs.
30
 For chemically 
controlled growth, small seed particles are either made through the citrate reduction 
method or using stronger reducing agents, most often sodium borohydride (NaBH4), and 
a surfactant capping agent, hexadecyltrimethylammonium bromide (CTAB). These 
CTAB-capped seed particles can then be grown iteratively into larger AuNPs, with 
controlled diameters of 5 – 150 nm showing excellent monodispersity.
34
 However, the 
CTAB used as a capping agent for these AuNPs is a cationic detergent, inducing 
cytotoxicity if it is not properly removed from the nanoparticle surface before biological 
applications. Other chemically controlled methods using citrate capped seeds have shown 





 as the reducing agent and involve the room 
temperature reduction of the gold salt onto the seeds while using citrate as a 
biocompatible capping agent to passivate and stabilize the AuNP surface (Figure 1.1B). 
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Figure 1.1 EM images of different AuNP sizes and shapes used in biomedical. (A) TEM 
of small, 15 nm nanospheres synthesized using the citrate reduction method, (B) TEM of 
large, 150 nm spheres synthesized via a seeded growth method, (C) nanorods, (D) SEM 
of nanoshells, (E) TEM of cubic nanocages with a 50 nm edge length, 5 nm wall 
thickness, and SEM inset, and (F) SEM of truncated nanocages with a 30 nm edge length 
and a high magnification TEM inset. (A) Adapted with permission from (
220
). Copyright 
(2016) American Chemical Society.  (B) Adapted with permission from (
221
). Copyright 
(2011) American Chemical Society. (C) Adapted with permission from (
122
). Copyright 
(2014) American Chemical Society. (D) Adapted with permission from (
14
). Copyright 
(2007) American Chemical Society. (E) Adapted with permission from (
41
). Copyright 





While significant efforts have gone into the synthesis of novel AuNP geometries, 
the most common solid, nonspherical AuNP geometry used for biomedical applications is 
the nanorod. Nanorods are generally made through seed mediated growth methods by 
synthesizing the seeds as described above, using NaBH4 to reduce the gold salt and 
CTAB to cap and stabilize the particles. The CTAB capped seeds were first used for 
nanorod synthesis by Nikoobakht and El-Sayed
36
 as well as Murphy et al.
37
 This method 
yielded gold nanorods (AuNRs) in relatively high yield by adding the seeds into an 
aqueous growth solution containing CTAB, gold chloride, silver nitrate, and ascorbic acid 
(Figure 1.1C). This is still the most widely used method for AuNR synthesis due to the 
yield and tunability of the nanorod aspect ratio (length : width ratio), which is achieved 
by simply adjusting the seed / gold salt ratio or the silver concentration. Other common 
nanostructures used in biomedical applications, include nanoshells and hollow 
nanocages. The use of gold nanoshells (AuNSs) was pioneered by the Halas group, who 
deposited small AuNPs onto a silica core (Figure 1.1D). The nanoshells were then 
generated through the chemical reduction of additional gold ions onto the particles using 
a mild reducing agent, resulting in the coalescence of the initially deposited small AuNPs 
and the generation of a uniform gold nanoshell on the surface of the silica core.
14, 38-39
 In 
contrast to nanorods and nanoshells, gold nanocages (AuNCs) are formed through a 
templated reaction introduced by Xia and coworkers.
13, 40-41
 In this method, silver 
nanocubes are first synthesized and then coated with a layer of gold. The silver core is 
then hollowed out by a galvanic replacement reaction, where 3 silver atoms are oxidized 
to silver (I) ions and a gold (III) ion is reduced to a gold atom due to the difference in 
their electrochemical potential. The etching of silver from the interior of the cube and 
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deposition of gold proceeds until the majority of the silver is consumed,
41
 resulting in a 
hollow frame or cage structure with a tunable size and thickness (Figure 1.1E and 1.1F). 





 and branched nanostructures
43, 47-50
 (Table 1.2). 
 
Table 1.2 Synthesis and LSPR properties of AuNPs 





Spheres 510 – 575 nm 5 – 150 nm Citrate reduction, 
Brust method, 
seeded growth 
25-26, 28, 30-31, 33
 
Nanorods 600 – 1200 nm 
(longitudinal) 
20 – 400 nm 
(long axis) x 







Nanoshells  520 – 1000 nm 60 – 250 nm  















650 – 1300 nm 40 – 400 nm 
(edge length) 










600 – 750 nm 40 – 300 nm Seed mediated, 






For biological applications, the surface chemistry of nanoparticles plays a crucial 
role in determining their targeting, uptake and clearance, stability, toxicity and 
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biocompatibility, and recognition by and interaction with biomolecules.
51-58
 Thus, 
specific passivating groups, typically polymers,
59-62





 DNA or RNA,
63, 69-70
 and small molecules,
71-72
 are often 
desired to promote uptake into specific cells or tissues, or to prevent uptake and increase 
circulation. Various conjugation strategies have been used to attach these ligands, 
through noncovalent interactions such as electrostatic adsorption or layer by layer (LbL) 
assembly, and covalent attachments (Table 1.3). 
 
Table 1.3 Summary of AuNP surface modifications 
Surface 
Chemistry 
Common ligands Application Conjugation 
technique 
References 
























54, 62, 79, 105, 224, 
226-228
 
Peptide RGD, NLS, TAT, 
ScFv(s) 











66, 68, 126, 185, 231-
233
 













Targeting, PDT Covalent 







LbL, pH or heat 
labile linkers 





During electrostatic adsorption, antibodies are bound to the AuNP surface by 
adjusting the solution pH around the isoelectric point of the protein to impart a slight 
positive or negative charge to that protein, allowing for conjugation to the charged 
AuNPs through electrostatic interactions.
67
 Electrostatic adsorption to AuNPs has also 
been extended to DNA.
73
 While a relatively straightforward conjugation technique, the 
primary drawbacks of electrostatic adsorption are denaturation of the protein upon 
binding, which can result in a decrease or loss of targeting due to the proteins’ 
conformational change, and the relative weakness of the interaction, which can result in 
desorption of the proteins or DNA under physiological conditions. To circumvent the 
electrostatic limitations, LbL assemblies can be used.
59
 These involve the encapsulation 
of the AuNPs by the adsorption of multiple polymer layers with alternating positive and 
negative charges
52
 (for example, CTAB capped nanorods would be coated with a 
negatively charged poly (styrene sulfonate) to allow for electrostatic coating, followed by 
a layer of positively charged poly (ethylene imine)
74
). LbL coatings allow for tunable 
AuNP surface charge, which can be used for electrostatic protein adsorption
75
 or gene 
delivery
74
. They can also be designed to incorporate hydrophobic and hydrophilic regions 
in the various layers and programmed to release them slowly.
21, 76
 This is a highly 
desirable characteristic for the delivery of therapeutic drugs with limited solubility or 
high clearance. 
Despite the inert nature of gold, it is known for the ability to form a relatively 
strong gold-thiol bond (Au-S) with molecules containing terminal thiols or disulfide 
bonds, often thought of as covalent or semi-covalent linkages.
77
 These attachments have 
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been investigated extensively in the context of self-assembled monolayers (SAMs), 
where thiolated molecules form a highly ordered monolayer on the gold surface. 
Accordingly, the strength of the gold-thiol bond (~ 45 kcal / mol; as a reference, 
disulfides, with bond energies of ~ 60 kcal / mol, stabilize proteins and help impart 
tertiary structure)
77
 has been widely used to functionalize AuNP surfaces. Thiolated 
polymers, most commonly poly (ethylene glycol) (PEG), are used to impart stability, 
hydrophilicity, and biocompatibility to AuNPs, while minimizing nanoparticle uptake 
and clearance, and preventing nonspecific protein adsorption.
62, 78-80
 Additionally, 
varying the terminal functional groups allows for the attachment of many different 







name a few. Heterobifunctional PEG thiol molecules, with terminal amine or carboxyl 
groups, are commonly used as a handle to attach proteins or peptides to AuNPs through 
carbodiimide coupling reactions, covalently linking the PEG functional group to the 
protein or peptide of interest. Alkyne or azide terminated PEG thiol molecules have also 
been adsorbed to gold and used to functionalize the AuNP surface through “click” 
chemistry reactions.
84-85
 Nucleic acids have also been attached to AuNPs by modifying 
the 3’ or 5’ ends with thiolated PEG linkers and used to promote cellular targeting and 
uptake, to generate 3D assemblies through hybridization of complementary strands,
86-88
 
for regulating gene expression,
89
 and as sensors for various proteins, target RNA strands, 




Multiple techniques are often used in parallel to characterize the size, shape, 
surface chemistry, aggregation state, and optical properties of AuNPs. Among the most 
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important methods is transmission electron microscopy (TEM) or scanning electron 
microscopy (SEM), which both allow for the direct observation of the size and shape of 
colloidal or substrate stabilized nanoparticles. While TEM and high resolution TEM 
(HRTEM) provide detailed information on nanoparticle size and crystal structure, SEM is 
often preferred to characterize non-spherical AuNPs due to the increased shape resolution 
provided by the scanning electron beam, allowing for an extra dimension (relative to the 
2D TEM) in the micrograph. The wider field of view during SEM measurements is also 
advantageous for analyzing images containing more AuNPs, providing greater insight 
into the monodispersity of the sample.
23-24
 
While electron microscopy involves the use of samples dried onto an appropriate 
electron microscopy (EM) grid and imaged under vacuum, dynamic light scattering 
(DLS) is often used in tandem to characterize AuNPs in solution. DLS measures 
fluctuations in scattered light intensity due to Brownian (i.e. random) motion of the 
particles in solution, which is then used to determine their diffusion coefficient and then 
related to the hydrodynamic radius of a sphere through the Stokes-Einstein relationship. 
DLS can generally be used in the pico- to nanomolar concentration range and for 
particles ranging from below 1 nm up to 10 μm. 92-94 However, the analysis becomes less 
reliable and more complex at higher concentrations or for non-spherical shapes due to 
multiple scattering events, where the incident photons are scattered multiple times before 
detection, and the varied scattering angles based on the orientation of the nanostructure. 
For these reasons, DLS is generally used as a complimentary method instead of a 
qualitative one, with an increase in hydrodynamic size indicating successful conjugation 
of a ligand or protein of interest. Nanoparticle surface chemistry is also measured in 
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solution to monitor colloidal stability or successful conjugation through ζ-potential 
measurements. Although the ζ-potential of colloids is not directly measurable, in practice 
it is calculated based on the electrophoretic mobility of the nanoparticles in solutions, or 
their ability to conduct an electrical charge on their surface. Accordingly, a change in ζ-
potential (the scale and magnitude of which depends on the initial surface chemistry of 
the AuNP and the molecule being conjugated) is indicative of successful conjugation due 
to the change in surface chemistry of the particles. For example, AuNPs made through 
the citrate reduction method have negative ζ-potentials upon synthesis (typically −30 mV 
to −50 mV), which become less negative or positive upon conjugation with PEG or 
targeting peptides. 80, 95  
Extinction spectroscopy is also used extensively to characterize the AuNPs optical 
response in the UV-Vis-NIR regions of the electromagnetic spectrum due to their 
characteristic LSPR band, which is sensitive to the nanoparticle size, concentration, 
morphology, aggregation state, and the quality of the colloidal dispersion (see 1.2 AuNP 
Optical Properties). The absorption of colloidal gold solutions at 400 nm, arising from 
atomic gold (i.e. Au
0
), has also been used to estimate AuNP concentration based on 
Beer’s Law and EM information about the particle size and shape.
96-97
 The number of 
atoms per AuNP can be estimated using its size and shape, and accounting for the crystal 
structure of gold, and then used to calculate the AuNP concentration in solution based on 
absorbance. A more accurate, albeit more expensive and time consuming, method for 
calculating AuNP concentration is through inductively coupled plasma (ICP), which is 
coupled with detection techniques such as mass spectrometry (ICP-MS), optical emission 
spectroscopy (ICP-OES), or atomic emission spectroscopy (ICP-AES). These techniques 
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involve the digestion of a AuNP solution with a known extinction, using concentrated 
aqua regia, which results in the dissolution of the nanoparticle into individual gold 
chloride ions. The gold concentration is then determined using ICP and correlated to 
AuNP size and shape through EM measurements to calculate the number of nanoparticles 
in solution. Thus, an extinction coefficient can be determined for a particular size and 
shape of AuNPs and used to rapidly calculate the colloidal concentration.67, 97-98 
Other techniques used to characterize AuNPs, although less common, include 
atomic force microscopy (AFM), 99-101 small angle X-ray scattering (SAXS), 102-104 energy 
dispersive X-ray spectroscopy (EDX), 105-108 and X-ray ray diffraction (XRD) 40, 109 (see 
Table 1.4 below). EDX is often used in conjunction with TEM or SEM to confirm the 
elemental composition of the nanostructure, which is particularly useful for core shell 
particles such as nanoshells, and bimetallic particles such as nanocages. 105-108 For smaller 
AuNPs (< 5 nm), which can be challenging to accurately size using EM, SAXS is often 
used in conjunction with electron microscopy to confirm AuNP size. An added benefit of 
SAXS measurements is the ability to be performed in situ, which allows for the evolution 
of nanoparticle growth to be monitored during synthesis.102-104 XRD can also be used as 
an elemental analysis technique to determine the metal content of bimetallic 
nanostructures and to approximate AuNP size by analyzing the broadening of the 
diffraction peaks using the Scherrer Equation. Although XRD can resolve size 
differences of ~ 1 - 2 nm, EM techniques have generally replaced XRD for AuNP size 
characterizations due to the significantly lower sample volumes needed for EM imaging 
and the ease of sample preparation, which often consists of simple drop casting of a few 
microliters of the colloidal AuNPs. It is however still commonly used to characterize 
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nanostructure crystallinity, which can have a significant effect on their optical response. 
In contrast to EM methods which must be used under vacuum, AFM is a scanning probe 
microscopy technique that can be used to analyze wet or dry samples, in addition to soft 
materials, and particles assembled into films or 3D structures. Although AFM has 
significantly lower lateral resolution than EM techniques (~ 20 – 30 nm for AFM and < 1 
nm for EM) due to convolution from the tip, AFM has excellent vertical resolution, often 
below 1 nm, which has been used to map the ligands on a nanoparticle surface and to 
monitor bioconjugation (for a detailed overview of AFM for bioconjugation applications, 




Table 1.4 Summary of AuNP characterization techniques 
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1.2 AuNP Optical Properties 
Gold nanoparticles have been used since ancient times due to their strong 
interactions with light, resulting in enhanced scattering and absorption properties.
3
 These 
properties are apparent in the distinct colors exhibited by colloidal gold solutions and 
arise from their localized surface plasmon resonance (LSPR). The LSPR results from the 
coherent oscillation of conduction band electrons through the metal nanoparticle, in 
resonance with incident light (Error! Reference source not found.). The frequency of the 
scillation depends on the size and shape of the AuNP, along with its composition 
(specifically the dielectric constant of the metal), the refractive index of the surrounding 
media, and coupling interactions between nanoparticles in close proximity.
111
 The excited 
LSPR of AuNPs can decay radiatively, in the form of light scattered by the nanoparticle 
at the same incident frequency. This enhanced electromagnetic field at the AuNP surface 
forms the basis of many optical and spectroscopic imaging applications. If the incident 
photon is instead absorbed, the plasmon decays non-radiatively through collisions 
between the excited electrons and metal lattice,
112
 resulting in heating of the solution 
surrounding the AuNP, which forms the basis of plasmonic photothermal therapy. 
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Figure 1.2 Schematic illustration of the LSPR, arising from the coherent oscillation of 
the AuNP conduction band electrons in resonance with incident light. 
 
1.2.1 Scattering 
The AuNP plasmon resonance leads to enhanced electromagnetic fields at the 
nanoparticle surface, resulting in immense scattering cross sections which can serve as 
powerful tools for imaging. The scattering by AuNPs is predicted by Mie theory, Gustav 
Mie’s solution to Maxwell’s equations for the scattering of light by spherical particles 
(with a diameter significantly smaller than the wavelength of incident light).
113
 The 
scattering by a single AuNP is 4 – 6 orders of magnitude larger than the emission from a 
typical organic dye or fluorescent protein, which allows for single particle imaging.
114
 An 
added benefit of AuNPs is their photostability; they do not bleach which allows for 





When light is scattered by a AuNP, it is emitted from the particle surface with the 
same energy as the incident excitation photon. This elastically scattered light forms the 
basis of optical imaging applications and is used extensively in dark-field microscopy.
7, 58
 
Dark-field imaging is commonly used because it is a sensitive, high contrast imaging 
modality but does not require expensive instrumentation or intensive sample preparation, 
simply a standard optical microscope equipped with a dark-field condenser. Broad, white 
light sources are used for excitation and the condenser ensures that the light is incident to 
the sample at high angles such that only light scattered by the sample is collected through 
the objective while the remaining excitation light passes undetected. While biological 
samples only weakly scatter white light, AuNPs strongly scatter light that coincides to 
their LSPR wavelength. Thus, the nanoparticles are seen as bright, colored spots (with a 
color corresponding to their LSPR wavelength) that contrast with the dark sample 
background (see 1.3.1 Optical Imaging for recent applications in bioimaging). 
While AuNPs scatter light with the same energy as the excitation photons, 
molecules in the nanoparticle vicinity interact with that elastically scattered light, leading 
to inelastic or Raman scattering. Raman scattering occurs when a molecule absorbs a 
photon, which is then emitted with a different energy. The difference in energy between 
the excitation photon and the emitted one is characteristic of a specific bond within the 
molecule. Thus, Raman spectroscopy presents a unique fingerprint of the bonds 
(specifically the vibrations of those bonds) within the molecule being studied. While 
Raman spectroscopy is highly suited for biological applications due to negligible 
interference from water, the main disadvantage is that Raman is an inherently weak 
spectroscopic imaging technique (~ 1 in 10 million photons is inelastically scattered); 
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therefore, high concentrations of the analyte being studied and / or high excitation laser 
intensities are typically required. However, the AuNPs can greatly enhance Raman 
signals due to their enhanced electromagnetic field in an effect termed surface enhanced 
Raman spectroscopy (SERS). For ensemble measurements, SERS typically achieves 
enhancements of 6 orders of magnitude relative to traditional Raman measurements, and 




 in some 
experiments, which has allowed for single particle and single molecule imaging. For 
recent applications of SERS in diagnostics, see 1.4.3 Surface enhanced Raman 
Spectroscopy (SERS), or refer to the recent review by Lane et al.
10
 for a more 
comprehensive discussion of SERS. 
1.2.2 Absorption 
In addition to scattered light, the AuNP may absorb the photon which results in 
the non-radiative decay of the plasmon resonance through collisions between the excited 
electrons (electron-electron interactions), between electrons and the metal lattice 
(electron-phonon interactions), and finally through collisions within the lattice (phonon-
phonon interactions). The collision of phonons, or oscillations within the metal lattice, 
generates heat surrounding the nanoparticle which can significantly increase the 
temperature of the surrounding medium. The photothermal conversion of light to heat by 
AuNPs is useful for biomedical applications, as it only occurs in the nanoparticle 
vicinity.
115
 Through rational design of the AuNP optical properties and surface chemistry, 
hyperthermia can be induced in selectively targeted cell populations without adversely 
affecting nearby untargeted tissues (see 1.3.2 Photoacoustic Imaging and 1.5.3 Plasmonic 
 21 
Photothermal Therapy (PPT) for recent applications in biomedical imaging and cancer 
treatment). 
1.2.3 Tuning AuNP Optical Response 
One of the most valuable properties of AuNPs is the tunability of their optical 
response, namely their scattering properties, absorption properties, and the frequency of 
their LSPR bands. The LSPR peak can be red-shifted to longer wavelengths, with a 
corresponding increase in intensity, by increasing the AuNP size. For example, a 
spherical 15 nm AuNP exhibits a plasmon resonance at ~ 518 nm, which shifts to ~ 530 
nm for a 30 nm particle, ~ 540 nm for a 60 nm AuNP (Figure 1.3), and the extinction 
coefficient for the particles increases by a factor of ~ 8 – 10 for both cases.
97
 
Additionally, the AuNP scattering and absorption properties can be tuned by adjusting 
the nanoparticle size. For particle diameters below 20 nm, the total light extinction is due 
almost entirely to absorption and the scattering contribution is negligible. As the AuNP 
size increases, the scattering to absorption ratio increases; while the total extinction for a 
20 nm AuNP is > 95% absorption, the total extinction from an 80 nm AuNP is ~ 50% 
absorption and ~ 50% scattering.
116
 These properties allow for the rational design of 
AuNPs for specific biomedical applications. For absorption based applications, such as 
photothermal therapy or photoacoustic imaging, smaller nanoparticles are preferred due 
to their greater light absorption efficiency, while for imaging, larger AuNPs are desirable 




Figure 1.3 Size, shape, and structure tunability of AuNPs optical properties. (A) Red-
shift of LSPR frequency with increasing AuNP size. (B) Tuning longitudinal LSPR of 
AuNRs with increasing aspect ratio. (C) Red-shift of LSPR frequency with decreasing 
nanoshell thickness. (D) Tuning LSPR frequency of nanocages with increasing gold 
concentrations during synthesis. (A) Adapted with permission from (223). Copyright 
2007 American Chemical Society. (B) Reprinted with permission from (8). Copyright 
2008 American Chemical Society. (C) Reprinted with permission from (14). Copyright 
(2007) American Chemical Society.  (D) Reprinted with permission from (123). 
Copyright 2007 Nature Publishing Group. 
 
In practice, tuning the LSPR frequency of spherical AuNPs is limited to ~ 50 nm 
because AuNPs with diameters above ~ 100 – 150 nm suffer from decreased stability, 
lower rates of cellular uptake, and increased dephasing of the plasmon as the particle size 
approaches that of the wavelength of light. Alternatively, the LSPR can be tuned by 
modifying the surface chemistry of AuNPs to assemble into 3D structures, often using 
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DNA templates, or to promote cellular uptake and aggregation into tightly packed 
vesicles (e.g. lysosomes, endosomes, etc.). When multiple AuNPs come into close 
proximity of each other, in 3D structures or in vesicles, the electromagnetic plasmon 
fields on adjacent nanoparticles couple together. This plasmon coupling results in a red-
shift of the LSPR frequency to longer wavelengths and a simultaneous increase in 
scattering intensity, relative to a single AuNP.
58
 Additionally, the coupled plasmon of 
AuNPs in close proximity is highly sensitive to separation distance, such that the 
observed LSPR shift of nanoparticle dimers has been used to measure nanometer 
separation distances. The ‘plasmon ruler’, first introduced by Alivisatos and 
coworkers,
117
 has recently been refined to measure distances as small as 5Å (0.5 nm),
118
 
and used to investigate molecular binding events,
119
 monitor drug response,
120
 and to 
measure enzyme activity,
119
 and a 3D plasmon ruler has recently been reported.
121
 Larger 
AuNP aggregates, such as those found in vesicles, are typically more difficult to analyze 
quantitatively due to their complex, dynamic structure but have shown imaging utility 
(see 1.3 Imaging). 
Additionally, the LSPR of AuNPs can be tuned by controlling the shape and 
structure of the nanoparticle. Considering non-spherical nanoparticles, AuNRs are among 
the most studied. By breaking the nanoparticle symmetry and elongating it into a rod, the 
AuNR conduction band electrons are able to oscillate in two directions, along the short 
axis and along the long axis of the nanorod, respectively. These two distinct electron 
oscillations result in two plasmon modes (i.e. LSPR bands). The transverse plasmon 
mode arises from electron oscillation along the short nanorod axis and the corresponding 
LSPR band appears at a similar frequency to a nanosphere with the same diameter. The 
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longitudinal mode, arising from electron oscillation along the long axis of the nanorod, 
results in the appearance of the second LSPR band at a longer wavelength.
112
 The 
frequency of the longitudinal mode is highly sensitive to the nanorod aspect ratio (length 
: width ratio), and the LSPR band can easily be tuned from ~ 650 nm to > 1100 nm 
simply by increasing the AuNR aspect ratio (Figure 1.3B).
122
 
Variations in AuNP structure, such as the nanoshell or nanocage, are also used to 
tune AuNP optical properties. In the case of nanoshells, introduced by Halas and 
coworkers, small AuNPs are deposited on a silica core and serve as seeds for the growth 
of the nanoshell. It was found that decreasing the shell thickness resulted in a red-shift in 
the LSPR band due to hybridization of the plasmon modes on the interior and exterior of 
the gold layer.
14
 Using the same 60 nm core size, decreasing the AuNS thickness from 20 
nm to 5 nm resulted in a ~ 300 nm red-shift in the LSPR band (Figure 1.3C). More 
recently, Xia and coworkers developed gold nanocages, hollow or porous nanostructures 
synthesized through the galvanic replacement of a silver nanocube with gold ions. The 
size and shape of the AuNCs were dictated by the silver nanoparticles used as templates 
in the synthesis. The thickness of the cage walls as well as the LSPR frequency was tuned 




Gold nanoparticles are used extensively in bio-imaging applications due to their 
strong, tunable optical properties, described previously. The intense scattering properties 
exhibited by AuNPs, with diameters typically in the 30 – 80 nm range for imaging, are 
readily detected and easily quantified using standard optical microscopes. Additionally, 
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modifying the AuNP size and shape allows for tuning of the LSPR wavelength within the 
“biological window” (650 – 1100 nm) where there is minimal attenuation by blood 
(specifically hemoglobin) and tissue, and imparts control over the scattering and 
absorption properties.
124-125
 This allows for both optical imaging using elastically 
scattered light, spectroscopic imaging using inelastically scattered light, and 
photoacoustic imaging using absorbed light. The tunable scattering and absorption 
properties of AuNPs, combined with their excellent photostability, have led to their use 
as powerful probes for cellular imaging, both in vitro and in vivo. 
1.3.1 Optical Imaging 
Bioconjugated AuNPs were first shown to distinguish between healthy and cancer 
cells in 2003 by Sokolov et al. through the use of laser scanning confocal reflectance 
microscopy.
126
 In this work, the authors utilized anti-EGFR antibody functionalized 
AuNPs that bind to EGFR, a transmembrane glycoprotein that is overexpressed in 
epithelial cancers,
127
 to selectively identify cancer cells. Seeing this work and knowing 
the strong light scattering properties of AuNPs, El-Sayed and co-workers set out to 
achieve the same outcome using a different imaging technique, dark-field microscopy 
(Figure 1.4A).
68
 Dark-field microscopy utilizes a white light source and a condenser that 
prevents centered light rays from reaching the sample of interest. This results in only 
scattered light entering the objective. The microscope can then be coupled to a color-
CCD camera for simple image collection. Through the addition of human anti-EGFR 
antibody conjugated spherical AuNPs, El-Sayed and co-workers were able to 
successfully distinguish between cancerous and noncancerous cells (Figure 1.4B). The 
authors confirmed their microscopy results with SPR absorption spectroscopy, which 
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showed an increase at 543 nm for cancerous cells due to the binding of AuNPs to the 
cancer cell surface. Antibody functionalized gold nanorods (AuNRs) and gold nanoshells 
(AuNSs) have also been utilized in dark-field microscopy assays.
128-129
 By switching to 
AuNRs or AuNSs, there is an added benefit that once identified, cells with increased 
nanoparticle binding can be irradiated with near-IR light resulting in their selective 
photothermal destruction. While the studies highlighted here focused on oral and breast 
cancer cells, this diagnostic imaging platform is extremely versatile and can be expanded 
to identify many other cancer cell types and cellular biomarkers. 
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Figure 1.4 (A) Schematic diagram of the main optical components for dark-field 
microscopy. (B) Dark-field images of cancerous and noncancerous cells treated with 
human anti-EGFR antibody conjugated spherical AuNPs. Cancerous cells showed 
increased AuNP light scattering intensities compared to noncancerous cells. Adapted 
with permission from (68). Copyright (2005) American Chemical Society. 
 
In addition to conventional dark-field microscopy, the simultaneous visualization 
and quantification of cell surface biomarkers could be achieved by coupling dark-field 
microscopy and colorimetric analysis of the AuNP scattered light in the acquired images. 
Recently, live cell dark-field microscopy has been used to monitor nano-bio interactions 
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in real-time. By modifying the traditional optical microscope to incorporate a temperature 
and atmosphere controlled incubator and using an angled incident white light source in 
place of a dark-field condenser, El-Sayed and coworkers designed a system to image the 
cellular interactions of AuNPs in real-time. Spherical AuNPs were conjugated with 
different ratios of RGD, a cell penetrating peptide, and a nuclear localizing sequence 
(NLS) peptide, and changes in scattering intensity and wavelength were monitored during 
cellular uptake and localization of the nanoparticles. The AuNPs with the highest ratio of 
NLS peptides (i.e. the most highly targeted particles) displayed the largest red-shift in 
scattering wavelength and the greatest scattering intensity, which was attributed to the 
formation of denser nanoparticle clusters. The increased scattering indicated that highly 
targeted AuNPs would be ideal probes for cellular imaging.
58
 Nuclear targeted AuNPs 
were then used as scattering probes to compare the efficacies of three commonly 
prescribed anticancer drugs, cisplatin, 5-fluorouracil (5FU), and camptothecin, which 
induce apoptotic cell death. Some characteristic morphological changes of apoptotic 
death include shrinking of the cell, membrane blebbing, and increased white light 
scattering. However, monitoring the scattering increase due to cell death, without the use 
of exogenous probes, was not a reliable method to compare drug efficacy. The addition of 
AuNPs, at a sufficiently low concentration that normal cell function was not perturbed, 
led to a significant increase in scattering upon cell death. Following the scattering 
increase over time yielded a profile of drug efficacy similar to that determined using a 
commercially available cell viability kit.
130
 The ability to monitor nanoparticle-cell 
interactions in real-time using inexpensive equipment, or to use AuNPs as probes to 
monitor cell processes with minimal perturbation, will likely lead to significant 
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advancements in the pharmaceutical field and increased biological applications of 
nanotechnology. 
1.3.2 Photoacoustic Imaging 
Photoacoustic (PA) imaging offers a proven in vivo imaging technique with high 
spatial resolution. In contrast to optical or spectroscopic imaging which use scattered 
light, PA imaging uses light that is absorbed by AuNPs. The absorbed energy is then 
converted to heat through electron-electron (~ 100 fs), electron-phonon (~ 1 ps), and 
phonon-phonon oscillations (~ 100 ps) within the AuNP.
112
 This relaxation process 
occurs very rapidly and results in intense heating at the nanoparticle surface. When the 
local nanoparticle environment is rapidly heated and the heat cannot dissipate quickly 
enough, a thermal expansion occurs. This expansion quickly collapses on itself and 
generates a photoacoustic (PA) wave, which is detected using an ultrasonic transducer 
and converted into an image.
124
 Photoacoustic signals are inherently weak, relegating the 
use of PA imaging to vascular structures due to the strong absorption of hemoglobin. 
Although tumor angiogenesis results in differing vasculature from healthy tissue,
131
 PA 
imaging does not possess sufficient contrast to distinguish between healthy and malignant 
vasculature. Thus, exogenous agents, such as AuNPs, are needed to increase the 
absorption, and therefore PA contrast, for tumor imaging applications. This was first 
reported by Oraevsky and coworkers, who assessed the contrast enhancement of 40 nm 
AuNPs conjugated with Herceptin to selectively target breast cancer cells and were able 
to detect nanoparticle concentrations as low as ~ 1 pM at depths up to 6 cm.
132
 This 
technique was later termed photoacoustic tomography (PAT) and used to successfully 
image malignant populations using AuNCs, resulting in a 63% contrast enhancement, and 
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AuNSs that achieved an 81% contrast enhancement. More recently, a combination 
magnetic resonance imaging (MRI), PAT contrast, Raman imaging nanoparticle was used 
to image brain tumors in vivo. Using a spherical AuNP core (for PAT contrast 
enhancement), coated with a Raman active layer and surrounded by a gadolinium shell 
(for MRI), the probe was developed to combine the benefits of all three imaging 
techniques into a single, multimodal nanoparticle probe while enhancing the stability of 
each individual method.
133
















As with many diseases, the development of earlier, more accurate, and cost 
effective detection assays is crucial for increasing cancer patient survival. With their 
unique optical and physical properties as well as relatively straightforward syntheses, 
AuNPs offer a promising alternative to traditional fluorescence and radiolabeled assays. 
Their strong light scattering allows for greater simplicity in assay designs while still 
maintaining, or even lowering, the detection limit for the analyte of interest. While these 
AuNP properties should be leveraged in developed countries to expedite disease 
detection, AuNP diagnostic assays may see the greatest clinical impact in regions with 
limited healthcare availability and where point-of-care diagnostics are required. 
1.4.1 Colorimetric Assays 
Colorimetric based assays are regarded as having a relatively simplistic, high-
throughput, and cost effective design. They are based on the color change of a solution, 
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which can often be seen by the naked eye, resulting from the aggregation of 
bioconjugated AuNPs after the introduction of a target analyte (Figure 1.5). Normally 
AuNPs exhibit a red wine color when in solution. However, when triggered, AuNPs can 
aggregate and undergo interparticle plasmonic coupling that causes their LSPR band to 
red-shift to longer wavelengths, leading to the adoption of a purple color in solution. This 
assay format was first described by Chad Mirkin and co-workers in 1997 when they 
utilized mercaptoalkyloligonucleotide modified AuNPs for the selective detection of 
polynucleotides via hybridization.
144
 Since this initial demonstration, the derivatization of 
this assay for the detection of disease relevant oligonucleotides and oligonucleotide 
mutations has been a popular research focus.
73, 145-149
 One such derivative has been 
described for the detection of bladder cancer through telomerase quantification.
150
 
Telomerase is a reverse transcriptase that is responsible for protecting chromosomes from 
DNA damage by adding a TTAGGG sequence to the end of telomeres.
151
 However, 
cancer cells have exploited this enzyme to evade cell death, and thus exhibit increased 
levels. In this work, AuNPs were conjugated to a telomerase primer as well as a reporter 
probe. If telomerase is present, primer elongation occurs resulting in the primers ability to 
bind to reporter probes on neighboring AuNPs. Absorbance ratios of 650 nm 
(aggregated)/520 nm (single AuNPs) were successfully utilized to classify 18 patients as 
those who were healthy vs. those that had bladder cancer. Furthermore, this assay 
provided a simplified experimental strategy for telomerase quantification compared to the 
traditional PCR-based TRAP method, which could potentially be translated to a point-of-
care assay employed in developing regions. 
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Figure 1.5 Schematic representation of the colorimetric assay format utilized to quantify 
cancer biomarkers. Biofunctionalized AuNPs are exposed to a target analyte that induces 
AuNP aggregation. Aggregation is detected by the red-shift in the AuNP’s LSPR. A color 
change in the AuNP solution from red to purple can also be observed, usually by the 
naked eye. 
 
Aptamer functionalized AuNPs have also been heavily utilized in colorimetric 
assays to detect the presence of cancer cells using both direct and indirect strategies.
152-155
 
Direct cancer cell detection was demonstrated by Medley et al. in 2008.
152
 T-cell human 
acute lymphoblastic leukemia and B cell human Burkitt’s lymphoma cells were mixed 
with AuNPs functionalized with aptamers specific for each cell type. Only when 
aptamer-AuNPs were added to their targeted cell solution did the red-shifted (aggregated) 
absorbance of the cell solution increase. The absorbance increased linearly with 
increasing cell concentration. In this proof-of-concept study, it was also determined that 
20 nm AuNPs exhibited the highest assay sensitivity when compared to 5, 50 and 100 nm 
AuNPs. The direct detection of breast cancer cells has also been demonstrated using a 
similar colorimetric assay strategy and two-photon light scattering detection.
155
 Indirect 
detection assays generally involve the incubation of a target aptamer solution with cancer 
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cells of interest and then the subsequent removal of unbound target aptamers. The 
unbound aptamers are then quantified by their ability to either hybridize and aggregate 
complementary aptamer-functionalized AuNPs or prevent aggregation of bare AuNPs in 
high salt solutions by providing particle stabilization. Recently, detection limits of 4-10 
cells were reported with both approaches when assaying in physiological buffers.
153-154
 
The true impact and utility of these platforms will be tested when these proof-of-concept 
studies expand into clinical samples, namely blood, where the biological matrix becomes 
increasingly more complex. If successful, these assays could see utility in circulating 
tumor cell detection. 
1.4.2 Dynamic Light Scattering (DLS) 
Coupling AuNPs and dynamic light scattering (DLS) can also result in simple, 
low-cost, and highly sensitive diagnostic biomarker assays. DLS was first introduced in 
the 1970s for polymer particle size analysis, and has since been expanded to monitor 
aggregated states of bioconjugated nanoparticles upon addition of a target analyte.
156
 In 
2008, Huo and co-workers demonstrated the utility of combing antibody functionalized 
AuNPs and DLS in the detection of free prostate specific antigen (f-PSA).
94
 Prostate 
cancer is responsible for 30,000 deaths in the United States. Early detection, when the 
disease is at a localized stage improves the five-year survival rate to 100% from a 
devastating 28% when the disease is found in a distant, metastatic state.
 157 156
 The 
combined analysis of f-PSA and total PSA has been researched as a promising metric for 
prostate cancer detection.
158
 The authors utilized detector and capture anti-PSA 
antibodies conjugated to spherical AuNPs and AuNRs, respectively. This assay format 
achieved a detection limit of 0.1 ng/mL. In follow up work by the same group, citrate 
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stabilized AuNPs were incubated with human serum samples and then exposed to rabbit 
anti-human IgG antibodies (Figure 1.6B).
159
 Serum samples that were from patients with 
prostate cancer showed increased hydrodynamic diameters after the addition of the rabbit 
anti-human IgG antibodies when compared to samples from healthy individuals. The 
increased diameter was attributed to the increased level of tumor-specific autoantibodies 
that were able to bind to the surface of the AuNPs. This work shows promising clinical 
impact, especially in resource sparce regions, as it is cost-effective, required only drops 
of blood, and the results are ready within minutes. While the direct clinical utility of this 
technique for cancer diagnostics has focused on antibody and protein biomarker 
detection, it has also been successful at detecting oligionucleotides, aptamers, and single 





Figure 1.6 (A) Schematic diagram depicting the two-step assay procedure to quantify the 
presence of tumor-specific autoantibodies. Citrate stabilized AuNPs were exposed to 
patient serum samples and then introduced to rabbit anti-human IgF antibodies. (B) 
Patient samples with increased levels of tumor-specific autoantibodies showed increased 
hydrodynamic diameters after the addition of rabbit anti-human IgG antibodies that bind 
to the patient’s autoantibodies. Adapted with permission from (
159
). Copyright (2015) 
American Chemical Society 
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1.4.3 Surface enhanced Raman Spectroscopy (SERS) 
Surface enhanced Raman spectroscopy (SERS) is a powerful technique that can 
provide rich spectroscopic information in the biological fingerprint region (600-1500   
cm
-1
) and has been employed in numerous in vitro and in vivo cancer diagnostic 
applications.
10
 Spontaneous Raman scattering is generally regarded as a very weak 
process with 1 in every 10
7
 photons being scattered. This rare event results in a weak 
signal and hinders its use in complex biological environments. However, when a 




 signal enhancement is 




Biomarker detection using SERS has been readily demonstrated in the 
literature.
10, 164
 AuNPs conjugated to mouse anti-human PSA antibodies and a Raman 
report, a molecule with a distinct, strong Raman signal, were used in conjunction with a 
gold film modified to contain mouse anti-human f-PSA antibodies for the detection of f-
PSA in human serum.
165
 The SERS sandwich assay provided a detection limit of 1 
pg/mL. A similar strategy was also employed for the detection of MUC4 in human serum 
samples with implications in pancreatic cancer detection.
166
 As MUC4 has not been able 
to be quantified using traditional enzyme linked immunosorbent assay (ELISA) and 
radioimmunoassay (RIA) assays, this work provided a huge step forward in MUC4’s 
potential use as a pancreatic cancer biomarker. Detection of circulating tumor cells 
(CTCs) was also shown to be possible with SERS.
167
 AuNPs were conjugated to an 
epidermal growth factor (EGF) peptide that can bind to EGFRs overexpressed on CTCs. 
The assay was first validated in squamous cell carcinoma of the head and neck (SCCHN) 
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cancer cells, Tu212 cells, spiked into mouse WBC samples. Patient samples were also 
evaluated, and 17 of 19 positive patient samples were identified using SERS. Multiplexed 
SERS assays are also possible by conjugating different Raman reporters to gold 
nanoparticles functionalized with different detecting biomolecules. This multiplex 






 cancer detection. 
Unlike the diagnostic strategies described previously, SERS also allows for in 
vivo cancer detection, and has shown potential intraoperative utility in tumor 
resections.
10, 164
 AuNPs are compatible with near-IR excitation sources that are necessary 
for in vivo imaging. The near-IR region is commonly referred to as the therapeutic 
window as tissue components (i.e. water and blood) have minimal absorption allowing 
maximum light penetration. One of the first demonstrations of utilizing SERS for in vivo 
tumor detection used AuNPs conjugated to single-chain variable fragment (ScFv) 
antibodies that can bind to EGFRs, and a Raman reporter, malachite green.
173
 The 
overexpression of EGFR on epithelial tumor cells provides the distinguishing component 
between diseased and healthy tissues. Mice treated with targeted AuNPs showed Raman 
signatures at the tumor site while mice treated with pegylated AuNPs showed Raman 
scattering in the liver. HER-2 positive tumors were also successfully imaged in vivo using 
ScFv-conjugated CyNAMLA-381 AuNPs in SKBR-3 nude mice xenograph models.
174
 
Administration of the functionalized AuNPs in a HER-2 negative xenograph model did 
not result in a detectable SERS signal demonstrating this method’s selectively.  
For surgical intervention to be successful a tumor must be fully resected and 
therefore clean margins must be achieved. Distinguishing between cancerous and 
noncancerous tissue in surgery can be difficult often leading to excess tissue being 
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removed or residual cancer tissues remaining. In an effort to bring real-time, sensitive 
feedback into the operating room some groups have focused on the use of AuNPs to 
amplify SERS signals at the tumor margins as well as combining SERS with other 
sensitive techniques including photoacoustic imaging and MRI to create surgical plans. In 
2012 Gambhir and co-workers reported the use of this strategy for successful SERS 
guided tumor resection of brain and ovarian tumors in mouse models.
133, 135
 AuNPs were 
administered intravenously and accumulated at the tumor site due to the enhanced 
permeability and retention (EPR) effect. Upon accumulation, SERS signals of chosen 
Raman reporters were detected and used to fine-tune tumor resection removing cancerous 
foci that were invisible to the naked eye, but were later confirmed through histology. 
Additionally, silica coated Raman active AuNPs and SERS were used for breast cancer 
tumor detection and phenotyping.
175
 In this work, the authors performed multiplexed 
SERS analysis on tumors by topically applying AuNPs that were labeled with EGFR, 
HER2 and isotype antibodies. The ratio of EGFR/isotype and HER2/isotype SERS 
signals allowed for the rapid (<15 min) quantitative molecular phenotyping of tumors. 
The authors suggest that this strategy could readily be employed intraoperative for breast 
cancer lumpectomies. 
Time resolved SERS (TR-SERS) has also shown potential utility for improving 
our understanding and evaluation of cancer cells. By using a live-cell imaging chamber 
that is compatible with a Raman microscope, it is possible to investigate important 
cellular processes, including cell cycle progression and cell death. PEGylated AuNPs 
equipped with RGD and nuclear localizing sequence (NLS) peptides to enhance cellular 
uptake and nuclear localization, respectively, were used to track a cell’s progression 
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throughout the cell cycle and identify Raman signatures that were correlated to each 
phase of the cell cycle.
176
 Raman signatures of cell cycle progression corresponded to the 
different production times of proteins and DNA. Apoptotic molecular events can also be 
distinguished using this methodology.
177
 In this work, El-Sayed and co-workers treated 
human oral squamous cell carcinoma (HSC-3) cells with 100 M of H2O2 to induce 
apoptosis and monitored the time dependent changes in SERS spectra. Tracking SERS 
signals over time as well as correlating these signal changes to in situ SERS experiments, 
a real-time sequence of apoptotic molecular events was obtained. Protein disulfide bond 
breakage along with DNA fragmentation was shown to occur first followed by the 
exposure of hydrophobic amino acids and the peptide backbone (loss of tertiary 
structure). Lastly, denatured proteins underwent peptide bond hydrolysis. While these 
studies demonstrate the usefulness of TR-SERS in mechanistic studies, TR-SERS’s 
greatest impact will most likely come from its ability to evaluate drug efficacy and 
delivery as these strategies could be readily adopted into high-throughput assays that 
could help identify promising cancer therapeutic candidates.
178-179
 By employing nuclear-
targeted AuNPs, TR-SERS was able to determine the relative efficacy of cisplatin and 5-
fluoruracil (5-FU) quicker than that of the traditional XTT cell viability assay (Figure 
1.7). In this work, SERS “death bands” were identified as their relative change over time 
resulted in an ET50 value that could be used as a comparison factor between the chosen 
chemotherapeutics. The SERS “death bands”, 1000 cm
-1
 and 1585 cm
-1
, were later 
associated with the amino acid phenylalanine and the DNA bases arginine and guanine, 
respectively.
177
 Real-time tracking of drug delivery was also shown with this technique 
through the exploitation of the nanoparticle plasmon effect.
178
 In this study, doxorubicin 
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(DOX) was covalently attached to the surface of nuclear-targeted AuNPs through a pH 
sensitive linker. When DOX was attached to AuNPs, its fluorescence was quenched, but 
its Raman signals were enhanced. Once the AuNPs were internalized within the cell and 
sequestered in the lysosome (pH 5), the pH sensitive linker was cleaved, releasing DOX. 
The release restored DOX’s fluorescence and eliminated the ability to detect is Raman 
vibrations. The inverse relationship between Raman and fluorescence at the surface of 
AuNPs was shown to be an effective mode of following drug delivery. Although the 
studies highlighted here utilized nuclear-targeted AuNPs, other organelle targeted AuNPs 









Figure 1.7 (A) Representative dark-field and TR-SERS spectra of HSC-3 cells treated with 





, green; 1585 cm
−1





, and (D) 1585 cm
−1
 – over time utilized to calculate the (E) ET50 of cisplatin and 5-FU 
for comparison of the TR-SERS method to the traditional XTT cell viability assay. Adapted with 
permission from (
178
). Copyright (2013) American Chemical Society. 
 
1.5 Cancer Treatment 
For the successful implementation of AuNPs as a therapeutic treatment for 
malignancy, the nanostructures must be biocompatible (to minimize off target effects or 
systematic toxicity) and exhibit preferential targeting of malignancy over healthy tissue. 
Multiple strategies are used to selectively target AuNPs to malignant cells or tumors for 
use as drug delivery vectors. Additional strategies involve the use of AuNPs as direct 
therapeutic agents to induce photothermal therapy, which encompasses cell death due to 
protein denaturation or membrane disruption, or photodynamic therapy, during which 
cytotoxicity in induced through the production of reactive oxygen species (ROS). 
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1.5.1 Tumor Targeting 
For effective cancer treatment, AuNPs must be designed to selectively target 
malignant cells and minimize off target effects toward healthy tissue. Several approaches 
are used to promote tumor targeting and / or cellular uptake for efficient cancer therapy, 
and are generally divided into two categories: (1) passive targeting and (2) active 
targeting. Passive targeting relies on the passive accumulation of nanoparticles within the 
tumor microenvironment due to the enhanced permeability and retention (EPR) effect.
181
 
While the vasculature supporting healthy tissues have tight junctions between endothelial 
cells, the angiogenesis associated with the rapid growth of malignancies results in leakier 
blood vessel walls with large fenestrations.
131
 This leakiness is the basis of the EPR 
effect, allowing nanostructures to pass through the porous blood vessels and accumulate 
within the tumor environment. Thus, nanoparticle size is a crucial factor in determining 
uptake via passive tumor targeting, with structures in the 30 – 200 nm size range 
displaying the best tumor retention.
181
 For the design of passively targeted particles, 
surface modifications such as PEG are often used for decreasing protein adsorption to the 
particles to shield the nanostructures from immune recognition and increase circulatory 
half-life.
78, 182-183
 Early investigations by Chan and coworkers used 20 – 100 nm PEG 




Various ligands have been used in attempts to improve tumor targeting through 









 and small molecules.
72, 105
 In general, these methods 
rely on the interaction between the nanoparticle surface ligand and a recognition element 
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expressed by the cancer cells. The active targeting ligands are used to target specific cell 
types, or specific organelles or proteins within those cells, with the hope of increasing 
local site accumulation. However, the enhancement in tumor accumulation provided by 
active targeting ligands is still the subject of debate due to the differences in size, shape, 
and surface chemistry of the nanostructures used, variations of targeting ligands and their 
coverage density, and the heterogeneity of tumor models studied.
12, 17
 
1.5.2 Drug Delivery 
The high surface area to volume ratio and facile surface chemistry of AuNPs 
make them ideal candidates as drug delivery vehicles that are easily loaded with large 
numbers of drug molecules. The concentration of a desired drug can be greatly increased 
within the tumor microenvironments through the use of passively and actively targeted 
AuNPs due to the high local concentration of the drug on the nanoparticle surface.
191
 In 
early applications, AuNPs served solely as carriers for therapeutic drugs. Paciotti et al. 
reported the first use of AuNPs as drug delivery vehicles, by covalently attaching tumor 
necrosis factor to the surface of 30 nm particles 
192
. These nanoparticle conjugates 
exhibited minimal systemic toxicity while showing enhanced efficacy at a lower 
concentration than the free drug. Many other cancer drugs have since been attached to 














. Drug-AuNP conjugates have also shown promise in overcoming drug 





While early examples of AuNPs as drug carriers showed promise, recent 
applications often involve the controlled release of the drugs at target sites. Thus, drug 
delivery can now be broken down into two components, drug loading to the nanostructure 
and delivery or release at the target site. A variety of covalent linkages, electrostatic 
adsorption, and hydrophobic / hydrophilic interactions (layer by layer assembly) have 
been used to conjugate AuNPs with the desired therapeutic agent (see 1.1.2 Conjugation 
for an overview of the chemistries involved). Various strategies are commonly used to 







 and timed release linkers
187
. 
1.5.3 Plasmonic Photothermal Therapy (PPT) 
Photothermal therapy involves the conversion of light to heat for the purpose of 
inducing hyperthermia in malignant cells, which occurs when cells are exposed to 
temperatures >42°C for several minutes, resulting in death from irreversible damage to 
protein and membrane structures. AuNPs serve as excellent probes for PPT due to their 
strong absorption that can be tuned to NIR wavelengths to minimize tissue attenuation 
during treatment. AuNSs, first developed by Halas and coworkers, were among the first 
nanostructures to be used for PPT.
39
 Using PEG conjugated nanoshells under 820 nm 
laser irradiation at 35 W/cm
2
 for 7 min, they observed significant cell death in the 
irradiated area, which was not observed for control cells without AuNSs. The nanoshells 
were then directly injected into tumors and cell death was again observed (820 nm laser 




 Subsequently, selective photothermal cell death was 
shown using anti-HER2 conjugated AuNSs to target HER2-positive SK-BR-3 breast 
cancer cells.
129
 El-Sayed and coworkers then demonstrated selective PPT using AuNRs 
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conjugated with EGFR antibodies. Under 800 nm continuous wave (cw) laser irradiation, 




 significantly lower 
than the initial in vitro experiments using AuNSs. Xia and coworkers then introduced 
AuNCs as PPT agents, inducing cell death at even lower laser intensities (808 nm, 0.7 
W/cm
2
), although with a longer 10 min irradiation.
202
 Other AuNP geometries with 
tunable optical properties that have also been used for PPT include nanoplates, 
nanoprisms, and branched nanoparticles. Current research is focused on optimizing the 
AuNP size and shape to increase the tumor accumulation and photothermal conversion 
efficiency of the particles so that lower laser powers are required for PPT. Additionally, 
identifying the specific mechanisms involved in cell death from PPT treatment is a key 
focus due to the conflicting reports of apoptotic and necrotic cell death present in the 
literature.
202-206
 These differences are likely due to variations in the nanoparticle targeting 
strategies, physical properties such as the particle absorption cross sections, and overlap 
between AuNP LSPR band with the treatment laser, and the duration and intensity of 
laser exposure. 
1.5.3.1 Photodynamic Therapy (PDT) 
In photodynamic therapy, a molecule or nanoparticle (i.e. a photosensitizer) is 
used to transfer energy from light to oxygen, converting it from the triplet ground state to 
the singlet state, a form of highly reactive oxygen species (ROS). This species reacts with 
cellular components such as DNA or proteins, causing irreversible changes in structure or 
function to induce cell death. The photosensitizer is only active when illuminated with 
light, affording selectivity in treatment location and duration. While organic dye 
molecules (e.g. cyanines or porphyrins) were traditionally used for PDT, they generally 
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suffer from nonspecific targeting and poor hydrophilicity which complicates delivery.
207
 
Thus, AuNPs are highly desirable as PDT agents due to their surface chemistry which 
can be modified to carry photosensitizers and improve hydrophilicity and tumor 
targeting. Russel and coworkers reported the use of AuNPs for PDT by stabilizing small 
2 – 4 nm gold particles with a photosensitizing phthalocyanine dye. These AuNP 
conjugates exhibited greater solubility, a ~50% increase in the quantum yield of singlet 
oxygen, and ~ 2.5 times greater tumor accumulation compared to the free dye.
208-209
 More 
recent research has focused on combining PDT with PPT
210-213
 for a multimodal approach 
to cancer treatment. 
Although organic PDT agents generally require UV or visible light to generate 
ROS, NIR light activation is highly desirable for its greater penetration depth. The 
tunability of AuNP optical properties, combined with their greater stability (organic PDT 
agents often exhibit poor water solubility and can decompose upon light exposure
214
), 
make them excellent candidates for PDT using NIR light. The use of AuNPs as direct 
photosensitizers capable of producing singlet oxygen upon light exposure (without 





 and aggregated nanospheres
219
 to produce 
various ROS including singlet oxygen, superoxide anions, and hydroxyl radicals. 
1.6 Conclusion 
The emergence of nanotechnology has resulted in the development of many new 
biomedical platforms with significant promise for the pharmaceutical industry. AuNPs 
have become promising candidates due to their well-established colloidal synthetic 
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routes, low cytotoxicity, straightforward surface modification with a variety of targeting 
or therapeutic ligands, and tunable optical properties. Specifically, AuNPs have been 
utilized in optical and photoacoustic imaging, diagnostic applications, as drug delivery 
platforms, and in direct cancer therapeutic applications such as plasmonic photothermal 
therapy or photodynamic therapy. Recent pharmaceutical applications of AuNPs 
increasingly combine several of these properties into single, multimodal platforms for 
theranostic functions. The increasing selectivity and efficacy of these multimodal 
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CHAPTER 2. BIOLOGICAL TARGETING OF PLASMONIC 
NANOPARTICLES IMPROVES CELLULAR IMAGING VIA THE 
ENHANCED SCATTERING IN THE AGGREGATES FORMED 
[1] 
(Adapted with permission from Aioub, M.; Kang, B.; Mackey, M. A.; El-Sayed, M. A. 
Biological Targeting of Plasmonic Nanoparticles Improves Cellular Imaging via the 
Enhanced Scattering in the Aggregates Formed. J. Phys. Chem. Lett. 2014, 5, 2555-2561. 
Copyright 2014 American Chemical Society.) 
Gold nanoparticles (AuNPs) demonstrate great promise in biomedical 
applications due to their plasmonically enhanced imaging properties. When in close 
proximity, AuNPs plasmonic fields couple together, increasing their scattering cross-
section due to the formation of hot spots, improving their imaging utility. In the present 
study, we modified the AuNPs surface with different peptides to target the nucleus and/or 
the cell as a whole, resulting in similar cellular uptake but different scattering intensities. 
Nuclear-targeted AuNPs showed the greatest scattering due to the formation of denser 
nanoparticle clusters (i.e., increased localization). We also obtained a dynamic profile of 
AuNP localization in living cells, indicating that nuclear localization is directly related to 
the number of nuclear-targeting peptides on the AuNP surface. Increased localization led 
to increased plasmonic field coupling, resulting in significantly higher scattering 
intensity. Thus, biochemical targeting of plasmonic nanoparticles to subcellular 





In recent years, the use of nanoparticles in the biomedical field has increased 
greatly due to their small size and unique physical, optical, and chemical properties.
2-5
 In 
particular, gold and silver metallic nanoparticles have been extensively studied due to 
their unique interaction with electromagnetic radiation, owing to their characteristic 
localized surface plasmon resonance (LSPR).
6-9
 The LSPR arises from the coherent 
oscillation of conduction band electrons, in resonance with the incident light of a 
particular frequency, which depends on the dielectric function of the metal, that of the 
medium, as well as the size, shape, and composition of the nanoparticle.
6, 10
 The LSPR 
results in a remarkably strong enhancement of the electromagnetic field localized at the 
nanoparticle surface, which is utilized in surface enhanced spectroscopy
11
 and solar 
energy applications.
12-14
 Additionally, the enhanced electric field (plasmonic field) of one 
nanoparticle can interact with that of an adjacent nanoparticle in close proximity, 
resulting in plasmon coupling.
15-18
 The interparticle coupling leads to an intense 
enhancement of the plasmonic field relative to that of a single nanoparticle.
18-19
 The 
LSPR of the coupled nanoparticles is red-shifted to longer wavelengths from the LSPR of 
a single nanoparticle, with a magnitude that depends on the proximity of the 




Gold nanoparticles (AuNPs) in particular have been increasingly utilized in a 




 and photothermal 
cancer therapy,
24
 due not only to their plasmonic properties, but also to their relatively 
low toxicity and facile surface chemistry.
3
 For many of these biomedical applications, 
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gold nanoparticles often need to be delivered intracellularly, and their nanoscale size 
allows AuNPs to be internalized by various types of cells through several endocytic 
processes.
25-27
 This can be achieved by chemical modification of the AuNP surface with 
targeting ligands, such as the cancer cell membrane targeting peptide (RGD), to 
selectively deliver AuNPs into cancer cells through receptor-mediated endocytosis.
25, 28-29
 
Also, chemical modification with a nuclear localization sequence (NLS) peptide can 
selectively deliver AuNPs to the cell nucleus.
26, 30-33
 Once AuNPs are internalized by 
cells, they are transported through subcellular vesicles and may accumulate in endosomes 
or lysosomes near the nucleus. During intracellular transport and localization, 
nanoparticles accumulate in subcellular components at different concentrations, which 
may depend on the size, shape, and most importantly, the surface chemistry of the 
nanoparticle. Therefore, understanding the localization of nanoparticles is critical to 
understanding their fundamental interactions within cells and improving their design for 
biomedical applications. To this end, the accumulation of AuNPs in endosomes and 
lysosomes has been observed by cryo-TEM,
34-35
 but the direct observation of the 
dynamics of nanoparticle localization in living cells still remains a challenge. Our group 
has previously observed the cellular uptake of gold nanoparticles by live-cell 
plasmonically enhanced Rayleigh scattering imaging techniques, which take advantage of 
the subcellular localization of AuNPs, resulting in the enhancement of AuNP Rayleigh 
scattering,
36-39
 but the dynamics of this AuNP localization remains unknown. 
In the present work, we have built a novel instrument and studied the cellular 
uptake and subcellular localization of AuNPs within living cells, in real-time, via single-
cell plasmonically-enhanced Rayleigh-scattering imaging spectroscopy (PERSIS). This 
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approach takes advantage of the characteristic optical properties of plasmonic AuNPs, 
namely, their ability to strongly scatter light, and the coupling of their plasmonic fields 
when particles come into close proximity. By monitoring the enhanced Rayleigh (elastic) 
scattering of different surface-modified AuNPs, the subcellular localization dynamics can 
be studied in real time. We have shown that the localization of AuNPs is dependent on 
the specific surface modification of the nanoparticles. Varying the amounts of the RGD 
and NLS peptides on the AuNP surface did not lead to a significant difference in the 
number of AuNPs internalized by the cancer cells, but large differences in the scattering 
intensity were observed due to the different surface modifications causing changes in 
AuNP localization within cells. Targeting AuNPs to the nucleus of cells increased the 
level of aggregation, leading to an increase in the total light scattered and a redshift to 
longer wavelengths, indicating enhanced coupling of the plasmonic fields due to 
decreased interparticle separation. Increasing the amount of NLS also caused the AuNPs 
to localize more rapidly, indicating that nuclear-targeted AuNPs may be more effective as 
imaging agents for biomedical applications, due to their greater light scattering ability 
and faster subcellular localization. This suggests that targeting subcellular components 
leads to greater localization, which offers an effective method of enhanced imaging using 
plasmonic nanoparticles. 
2.2 Methods 
2.2.1 AuNP Synthesis 
For these studies, Citrate-stabilized AuNPs with an average diameter of 31 nm 
were synthesized by the reduction of chloroauric acid via sodium citrate.
40
  Briefly, 490 
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mL of a 0.6 mM aqueous solution of chloroauric acid (Sigma-Aldrich) was heated in a 1 
L Erlenmeyer flask, with stirring. When the solution reached boiling, 10 mL of a 180 mM 
trisodium citrate (Sigma-Aldrich) in water solution was immediately added. Stirring and 
heating were discontinued when the solution became a red-wine color and it was allowed 
to cool to room temperature. TEM images (Figure 2.1) were taken on a JEOL 100CX-2 
transmission electron microscope and the average particle diameter was found to be 31 
nm using ImageJ software. UV–Vis spectroscopy showed a surface plasmon resonance 




Figure 2.1 Characterization of targeted AuNPs. UV–Vis spectrum of AuNPs before 
(black) and after conjugation with mPEG-SH5000 (red), and varying molar ratios of RGD 
and NLS peptides (blue, pink, and green) in aqueous solution. There was a slight red shift 
in the plasmon peak indicating successful conjugation. The inset shows a TEM 
micrograph of 31 ± 4 nm citrate-capped AuNPs. 
 
2.2.2 AuNP Functionalization 
The citrate-capped AuNPs were stabilized with polyethylene glycol thiol (mPEG-SH5k) 
to prevent nonspecific interactions under physiological conditions.
29
 A 1.0 mM solution 
of mPEG-SH (MW 5000, Lysan Bio, Inc.) in deionized (DI) water was added to achieve 
a ~30% surface coverage. The PEG-AuNP solution was shaken overnight at room 
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temperature and unbound PEG was removed by centrifugation (6000 rpm, 14 min). 
Washed PEG-AuNPs were redispersed in DI water and characterized by UV–Vis 
spectroscopy (Figure 2.1). The PEG-AuNPs were then modified with RGD 
(arginine−glycine−aspartic acid) and NLS (nuclear localization signal) peptides. The 
RGD peptide allows for receptor-mediated endocytosis of AuNPs by targeting αvβ6 
integrins, which are overexpressed on the surface of human oral squamous carcinoma 
(HSC-3) cells.
29
 The NLS peptide has a characteristic KKKRK 
(lysine−lysine−lysine−arginine−lysine) sequence, which binds importins in the cytoplasm 
of the cell, allowing for translocation of AuNPs to the nucleus.
26, 30-31
 Peptide conjugation 
was utilized to design three different surface-modified AuNPs: RGD-AuNPs, 
RGD1/NLS1-AuNPs having equal amounts of RGD and NLS peptides, and RGD1/NLS10-
AuNPs with RGD1/NLS10-AuNPs containing 10 times the NLS content of RGD1/NLS1-
AuNPs. Previous work has shown that both RGD and NLS peptides indeed promote 
cellular uptake and localization of AuNPs at the nucleus, respectively.
39, 41-42
 Briefly, 5.0 
mM solutions of NLS (CGGPKKKKRKVGG) in DI water and / or RGD 
(CGPDGRDGRDGRDGR) in DI water were added to the PEG-AuNPs.  A total of 4,000 
peptides per PEG-AuNP were added in equal molar amounts of RGD and NLS for 
RGD1/NLS1-AuNPs, a 10:1 ratio of NLS/RGD for RGD1/NLS10-AuNPs, and only RGD 
was added for RGD-AuNPs. The peptide-nanoparticle solutions were allowed to shake 
overnight at room temperature and excess peptides removed by centrifugation (6000 rpm, 
14 min). The desired concentration of 0.4 nM AuNPs was achieved by diluting stock 
AuNPs in cell culture medium. 
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2.2.3 Cell Culture 
Human oral squamous carcinoma (HSC-3) cells, a malignant epithelial cell line 
expressing αvβ6 integrins on the cell membrane, were chosen as our cancer cell model.
2
 
The cells were cultured in Dulbecco's modification of Eagle's medium (DMEM, 
Mediatech) supplemented with 4.5 g/L glucose, L-glutamine, and sodium pyruvate, 10% 
v/v Fetal Bovine Serum (Mediatech), and 1% v/v antimycotic solution (Mediatech). Cell 
cultures were kept in a humidified 37°C incubator with an atmosphere of 5% CO2. 
2.2.4 Cell Viability Assay 
To assess the viability of HSC-3 cells treated with targeted AuNPs, cells were grown in 
96-well plates overnight. The growth medium was then removed and replaced with 
culture medium containing 0.4 nM AuNPs. After 24 hour incubation, the AuNP 
containing culture medium was replaced with an XTT solution (Biotium, Inc.) in DMEM. 
Cells were then incubated with the XTT solution for 4 h and absorbance measurements 
were taken at 450 nm and 690 nm on a Biotek Synergy H4 Multi-Mode Plate Reader. 
Cell viabilities are shown as the mean ± s.e.m. of three independent. 
2.2.5 AuNP Uptake 
The percentage of AuNPs taken up by HSC-3 cells was determined using a 
previously established spectroscopic technique.
1
 Briefly, cells were grown in 96-well 
tissue culture plates overnight. The growth media was then replaced with medium 
containing 0.4 nM AuNPs. After 24 h incubation with AuNPs, the nanoparticle 
containing culture medium was moved to a new 96-well culture plate. The optical density 
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was measured at a wavelength of 538 nm (Biotek Synergy H4 Multimode Plate Reader). 
To determine AuNP uptake, the measured optical density of culture medium without 
AuNPs was subtracted from the optical density of the AuNP containing treatment 
medium. This AuNP optical density was then converted to a percentage of that initially 
added to the cell culture. 
2.2.6 PERSIS Technique 
The PERSIS system is composed of a home-made live cell incubator, a 
spectrometer (USB2000+, Ocean Optics), and a dark-field microscope. To obtain 
scattering spectra, cells were grown overnight on a glass-bottom culture dish (MatTek) in 
DMEM. The growth medium was then removed and the cells treated with solutions of 0.4 
nM AuNPs in DMEM and immediately moved to the PERSIS live-cell incubator located 
on the microscope stage. The incubator maintained the cells at 37°C in a humidified 
atmosphere containing 5% CO2. The PERSIS system angled a beam of white light onto 
the sample such that incident light passed through the sample and only scattered light was 
collected into the 40X microscope objective. The collection area was controlled by a 0.6 
mm pinhole and the magnification of the objective, with an absolute collection area of 
roughly 3 μm x 3 μm (~10 μm2 collection area), allowing for single cell resolution. A 
CCD camera was used to capture the true-color Rayleigh scattering images from the cells 
and spectral signals were coupled into an optical fiber and recorded. 
2.2.7 Spectral Analysis 
Scattering spectra were collected and averaged from 10 different cells and all 
experiments were performed in triplicate. Reference spectra were taken immediately 
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upon addition of AuNP to cells and subtracted from subsequent time points to remove 
any scattering from cells or the AuNP/culture medium background. Spectra were then 
deconvoluted into three Gaussians using OriginPro 9.0 software (Origin Lab, Corp.). The 
first Gaussian was fixed at 538 nm to correspond to the plasmon peak of single AuNPs 
(Figure 2.1). The peaks due to small and larger AuNP clusters were centered between 
636 – 646 nm and 740 – 750 nm, respectively, and the best fit integrated to give 
intensities of the Rayleigh scattered bands. Scattering intensities were fit to a sigmoidal 
growth curve using a logistic response function with OriginPro 9.0 software. Initial and 
final scattering values were used to generate the scattering half-times, defined as the time 
required to reach the median of the fit between these values. The power of the logistic 
fitting function was assumed to be non-negative and the curve fit was optimized using the 
Levenberg Marquardt algorithm. 
2.2.8 Statistical Analysis 
Results are expressed as the mean ± s.e.m. of three independent experiments. 
Changes in scattering intensity were compared using a linear regression analysis 
calculator and the changes were not considered statistically significant (p = 0.1388). 
Statistical significance of AuNP uptake was calculated using unpaired t-tests (GraphPad 
Software, Inc.), and the difference in uptake between the AuNPs studied was not found to 
be statistically significant. The viability of cells treated with targeted AuNPs were also 
compared to untreated controls using unpaired t-tests (GraphPad Software, Inc.), and 
differences between the AuNPs studied were not found to be statistically significant. 
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2.3 Results and Discussion 
2.3.1 PERSIS Design and Technique 
Since the endocytosis of AuNPs results in specific subcellular localization, we can 
observe the plasmonic coupling of single particles as they are internalized and come in 
proximity with other AuNPs.
43-44
 As represented by Figure 2.2A, the degree of AuNP 
localization within cells can vary. At the early stages of cellular uptake, the nanoparticles 
bind to receptors on the cell surface and are internalized into the cytoplasm to form small 
clusters of particles.
45
 This results in a redshift in the surface plasmon band from the 
single nanoparticle wavelength (538 nm) to longer wavelengths (641 nm), due to 
coupling of the plasmonic fields between AuNPs as they localize and aggregate.
45-46
 
Subsequently, the AuNPs begin to form larger clusters as they accumulate in the 
endosomes or lysosomes and localize at the perinuclear region,
44-45
 causing a further shift 
in the plasmon band to even longer wavelengths (745 nm).
47
 By monitoring the coupling 
of the plasmon bands, observed as a redshift in the LSPR, the dynamics of nanoparticle 
uptake and localization in single living cells can be followed in real time with our single-
cell plasmon-enhanced Rayleigh scattering imaging spectroscopy (PERSIS) technique. 
Additionally, the Rayleigh scattering spectra from cells without AuNP treatment do not 
show any significant changes over time (Figure 2.3), indicating that the observed 
changes are due to AuNP uptake and localization. Shown in Figure 2.2, our PERSIS 
system is composed of a homemade live cell incubator, a spectrometer to collect 
Rayleigh scattering spectra, and a dark-field microscope with an attached CCD camera to 
record the Rayleigh scattering images. This allows for the real-time monitoring of AuNP 
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uptake and localization in living cells, by analyzing the scattering intensity in dark-field 
images and the plasmon band redshift of the Rayleigh scattering spectra over time.  
 
 
Figure 2.2 Schematic of nanoparticle localization by the PERSIS system. (A) Schematic 
representation of gold nanoparticle localization within cells during the process of cellular 
uptake; (B) Diagram of the experimental setup and the measurement of nanoparticle 








Figure 2.3 (A) Rayleigh scattering spectra of HSC-3 cells without AuNP treatment show 
no change with time. (B) Scattering intensity of untreated cells does not change 
significantly with time (p = 0.139). 
 
2.3.2 Localization kinetics using Plasmonically-Enhanced Rayleigh Scattering 
To ensure that changes in the observed scattering intensity were due to AuNP 
uptake (and not influenced by cell death), a treatment concentration of 0.4 nM AuNP in 
culture media was chosen for these studies. After 24 h, the viability of treated cells was 
measured using an XTT cell viability assay, and no significant cell death was observed 
from the three AuNP designs studied (Figure 2.4). Due to the αβ integrin targeting ability 
of RGD, all three AuNP samples studied also demonstrated similar levels of overall 
uptake (~30%, Figure 2.5). However, the intracellular localization of the different 




































AuNPs varied based on the AuNP surface modification. As suggested by the live-cell 
Rayleigh-scattering dark field images in Figure 2.6, the AuNPs containing NLS peptide 
(Figure 2.6, middle and bottom) show higher AuNP localization at the nucleus compared 
to AuNPs without NLS (Figure 2.6, top). Additionally, an increase in NLS peptide 
content (RGD1/NLS10-AuNPs) results in a more rapid localization rate of AuNPs at the 
nucleus (Figure 2.6, bottom). 
 
 
Figure 2.4 Viability of HSC-3 cells after 24 h of incubation with targeted AuNPs.  No 












































Figure 2.5 Cellular uptake of targeted AuNPs by HSC cells after 24 hours, shown as 
percentage of AuNPs taken up ± s.e.m. No statistically significant difference in uptake 





































Figure 2.6 Real-time Rayleigh scattering dark-field images of cellular uptake of gold 
nanoparticles with different surface modifications: (top) RGD-AuNPs, (middle) 
RGD1/NLS1-AuNPs, (bottom) RGD1/NLS10-AuNPs. Scale bar: 10 μm. 
 
From these Rayleigh scattering dark-field images, our PERSIS technique allows 
us to obtain Rayleigh scattering spectra of AuNPs in living cells. Accordingly, spectra 
were collected for the various AuNPs tested over a 24 h period as shown in Figure 2.7. 
The entire spectrum obtained at each time point was integrated to give the total scattering 
intensity for each different surface modified AuNP, and is shown in Figure 2.8. From 
these integrated scattering intensities, a scattering half-time (see 2.2.7 Spectral Analysis) 
for each different surface-modified AuNP to estimate the rate at which the AuNPs 
localize within cells. RGD-AuNPs were found to have a scattering half-time of 11.4 h, 
while RGD1/NLS1-AuNPs exhibited a faster scattering half-time of 6.7 h. RGD1/NLS10-
AuNPs had the fastest scattering half-time of just 2.9 h. In addition to the faster half-time, 
indicating more rapid AuNP localization within cells, the RGD1/NLS10-AuNPs exhibit a 
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AuNPs and RGD1/NLS1-AuNPs. This indicates that higher concentrations of NLS on the 
AuNP surface leads to an increased concentration of localized AuNPs at the perinuclear 
region, as evidenced by their more rapid increase in scattering, greater scattering 
intensity, and greater interparticle coupling of the plasmonic fields (i.e., greater intensity 
of the red-shifted plasmon peaks). 
 
Figure 2.7 Real-time Rayleigh scattering spectra of AuNP uptake and localization within 
living cells for (A) RGD-AuNPs, (B) RGD1/NLS1-AuNPs, and (C) RGD1/NLS10-AuNPs. 
The deconvoluted peaks show the plasmonic scattering bands of single nanoparticles 
(538 nm), small AuNP clusters (641 nm), and large AuNP clusters (745 nm) and the 
center of the Gaussian fits are denoted by dashed lines. 
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Figure 2.8 Dependence of the rate of increase of the scattered light intensity on the type 
of nanoparticle surface capping material, shown as the mean ± s.e.m. of three 
independent experiments. This figure shows that the higher the concentration of NLS (the 
nuclear localization sequence), the higher the observed rate of the scattered light intensity 
increases. The calculated scattering half-times are given above for RGD-AuNPs (black, 
R
2 
= 0.993), RGD1/NLS1-AuNPs (red, R
2 





2.3.3 AuNP Localization Dynamics 
 The overall scattering spectrum shown in Figure 2.8 not only describes the total 
amount of light scattered by the different AuNPs in cells over time, but it can also 
provide a detailed dynamic profile of AuNP aggregation and localization. This 
subcellular localization results in the formation of AuNP clusters with smaller 


















































interparticle separations, leading to stronger coupling of their plasmonic fields and 
therefore, large red-shifted plasmon peaks. Thus, the total scattering spectrum obtained 
was fit to multiple Gaussians, allowing its deconvolution into three components: (1) 
AuNP monomers indicated by the plasmon band at 538 nm, (2) small AuNP clusters 
(with higher local concentrations of AuNPs, relative to AuNP monomers, which do not 
have interacting plasmonic fields), having a plasmon band at 641 nm, and (3) larger 
clusters of AuNPs (with the highest local AuNP concentration, indicating even greater 
coupling between the plasmonic fields of AuNPs in close proximity) give scattering at 
the longest wavelength of the 745 nm plasmon band (all are denoted with the dashed 
lines in Figure 2.7). Although the spectrum for each different AuNP contains these three 
components, the bands vary significantly based on the AuNP surface modification, 
indicating varying degrees of localization (i.e., different local concentrations of AuNPs 
within cells). In order to compare these bands for the different surface modified AuNPs 
and obtain detailed information on their degree of localization, the small (641 nm) and 
large (745 nm) AuNP cluster bands were integrated to give their total scattering 
intensities, as shown in Figure 2.9A and 2.9B, respectively. From these integrated 
scattering intensities, we again calculated a scattering half-time for each different surface 
modified AuNP tested, to give a measure of how quickly the different AuNPs with 
different surface biochemical capping become localized.  
During the formation of smaller AuNP clusters (Figure 2.9A), RGD-AuNPs and 
RGD1/NLS1-AuNPs showed similar scattering intensities after 24 h. However, 
RGD1/NLS1-AuNPs had a shorter small cluster half-time of 5.4 h, compared to 6.4 h for 
the AuNPs without the NLS peptide. The RGD1/NLS10-AuNPs were found to have the 
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shortest small cluster half-time of 2.7 h, while showing a scattering intensity almost twice 
as large as that of the small cluster. This suggests that the increased amount of NLS 
peptides enhanced the rate of formation of small AuNP clusters at the perinuclear region. 
During the formation of the larger AuNP clusters (Figure 2.9B), NLS-modified 
particles (RGD1/NLS10-AuNPs and RGD1/NLS1-AuNPs) showed similar scattering 
intensities after 24 h. However, the AuNPs containing more NLS peptides (RGD1/NLS10-
AuNPs) exhibited a shorter large cluster half-time of 3.3 h, compared to the 7.4 h for 
AuNPs containing less NLS peptide. Again, we attribute the shorter half-time to the 
increase in NLS peptides on the AuNP surface, enhancing the rate of nanoparticle 
localization at the nucleus or the nuclear membrane. The RGD-AuNPs were found to 
have the longest large cluster half-time of 8.1 h, while demonstrating a large aggregate 
scattering intensity almost five times smaller than the AuNPs bound to the NLS peptides. 
These results suggest that nuclear-targeted AuNPs tend to form more dense clusters 
having larger scattering cross sections, as they are bound to the small perinuclear region, 




Figure 2.9 Dynamics of scattered light intensity for bands of (A) small AuNP clusters at 
641 nm and (B) large AuNP clusters at 745 nm. Localization half-times of small AuNP 
clusters were calculated to be 6.4 h for RGD-AuNPs (black, R
2 
= 0.995), 5.4 h for 
RGD1/NLS1-AuNPs (red, R
2 
= 0.997), and 2.7 h for RGD1/NLS10-AuNPs (blue, R
2 
= 
0.979). Localization half-times of large AuNP clusters were calculated to be 8.1 h for 
RGD-AuNPs black, R
2 
= 0.989), 7.4 h for RGD1/NLS1-AuNPs (red, R
2 
= 0.996), and 3.3 





In conclusion, we have developed an instrument and demonstrated its use of 
PERSIS to monitor the dynamics of AuNP uptake, localization and aggregation of 
plasmonic nanoparticles with different capping materials. The AuNP surface 
modification greatly affected their localization and led to decreased interparticle 
separation between AuNPs, causing great enhancement of the scattered light and a red-
shift in their observed plasmonic spectral peak to longer wavelengths. Nuclear-targeted 
AuNPs, directed to the smaller volume of the nucleus, were found to localize more 
rapidly than those not targeted to the nucleus of the cancer cells. This also leads to the 
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spots are known to have much more enhanced plasmonic fields leading to stronger 
scattering and thus better imaging of the region targeted by the nanoparticles. Increasing 
the concentration of the NLS peptides on the AuNP surface increased the localization rate 
and the concentration of the plasmonic nanoparticles at the NLS target in the cell. It is 
clear that this technique is not limited to studying the nuclear region. Various peptides are 
known to target different cellular components and the addition of a terminal thiol group 
would make it possible to conjugate the AuNPs for enhanced imaging at the selected 
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CHAPTER 3. DETERMINING DRUG EFFICACY USING 
PLASMONICALLY-ENHANCED IMAGING OF THE 
MORPHOLOGICAL CHANGES OF CELLS UPON DEATH 
[1] 
(Adapted with permission from Aioub, M.; Austin, L. A.; El-Sayed, M. A. Determining 
Drug Efficacy Using Plasmonically Enhanced Imaging of the Morphological Changes of 
Cells Upon Death. J. Phys. Chem. Lett. 2014, 5, 3514-3518. Copyright 2014 American 
Chemical Society.) 
Recently, we utilized the optical properties of gold nanoparticles (AuNPs) for 
plasmonically enhanced Rayleigh scattering imaging spectroscopy (PERSIS), a new 
technique that enabled the direct observation of AuNP localization. In this study, we 
employ PERSIS by using AuNPs as light-scattering probes to compare the relative 
efficacy of three chemotherapeutic drugs on human oral squamous carcinoma cells. 
Although the drugs induced apoptotic cell death through differing mechanisms, 
morphological changes including cell membrane blebbing and shrinkage, accompanied 
by an increase in white light scattering, were visually evident. By utilizing the AuNPs to 
increase the cells’ inherent Rayleigh scattering, we have obtained the time profile of cell 
death from the anticancer drugs using a single sample of cells in real time, using 
inexpensive equipment available in any lab. From this time profile, we calculated cell 
death enhancement factors to compare the relative efficacies of the different drugs using 
our technique, which corresponded to those calculated from the commonly used XTT cell 
viability assay. Although this technique does not impart molecular insights into cell 
death, the ability to quantitatively correlate cell death to morphological changes suggests 
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the potential use of this technique for the rapid screening of drug analogues to determine 
the most effective structure against a disease or cell line. 
3.1 Introduction 
Plasmonic nanoparticles have been heavily utilized in the biomedical field due to 
their small size and unique physical, optical, and chemical properties.
2-5
 In particular, the 
plasmonically enhanced scattering of gold nanoparticles (AuNPs) has been used in 
cellular imaging applications to differentiate cancerous from noncancerous cells
6
 and in 
surface-enhanced Raman spectroscopy to observe the molecular dynamics of apoptosis
7
 
and to detect biomarkers in complex physiological environments.
8
 We recently developed 
a new technique, plasmonically enhanced Rayleigh scattering imaging spectroscopy 
(PERSIS), which enabled cellular imaging and the observation of AuNP localization. The 
AuNP localization caused a change in the intensity and the wavelength of light scattered 
by the nanoparticles as they came into close proximity.
9
 Here, we utilize this technique, 
specifically the change in scattering intensity, to study the relative efficacy of three 
anticancer drugs (cisplatin, camptothecin, and 5-fluorouracil (5-FU)) in human oral 
squamous carcinoma (HSC-3) cells. This technique is validated against a commercially 
available XTT cell viability assay. 
Normal progression through the cell cycle plays a critical role in the health and 
proliferation of living cells. Perturbations in this cycle can cause the loss of essential 
cellular functions or unwanted mutations, necessitating safeguards such as apoptosis, 
which results in the programmed death of cells that have mutated (i.e., become 
malignant) or lost vital functions.
10
 Not surprisingly, many anticancer drugs attempt to 
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induce apoptosis in these malignancies, often by disrupting DNA synthesis or 
replication.
11-13
 However, the precise mechanism of action differs between drugs, leading 
to fluctuations in efficacy based on the cells’ current phase in their replication cycles. For 
example, camptothecin inhibits DNA topoisomerase I, making it most effective during 
the S-phase,
14
 whereas cisplatin forms DNA cross-link adducts leading to increased 
cellular sensitivity in the G1-phase,
15
 and 5-FU blocks DNA synthesis by inhibiting 
thymidylate synthase and incorporation into RNA, causing G1/S-phase arrest.
16
 Despite 
the differing mechanisms of action for these drugs, the morphological characteristics of 
apoptotic cell death are retained, specifically cell shrinkage, membrane blebbing, and 




3.2.1 AuNP Synthesis 
Citrate–capped AuNPs with an average diameter of 31 nm were synthesized by 
the sodium citrate mediated reduction of chloroauric acid.
1
 Briefly, 98 mL of a 0.6 mM 
solution of aqueous chloroauric acid (Sigma-Aldrich) was heated, with stirring, in a 250 
mL Erlenmeyer flask. When the solution boiled, a 2 mL aqueous solution of 180 mM 
trisodium citrate (Sigma-Aldrich) was immediately added. When the solution became a 
wine-red color, stirring and heating were discontinued, and the solution was allowed to 
cool to room temperature. TEM images (Figure 3.1) were taken with a JEOL 100CX-2 
transmission electron microscope and the average particle diameter was found to be 31 ± 
4 nm using ImageJ software. UV–Vis spectroscopy showed a surface plasmon resonance 
peak at 534 nm (Figure 3.1). 
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Figure 3.1 Characterization of nuclear-targeted AuNPs (NT-AuNPs). UV–Vis spectrum 
of AuNPs before (black) and after conjugation with mPEG-SH5000 (red), and RGD and 
NLS peptides (blue) in aqueous solution. There was a red shift in the plasmon peak 
indicating successful conjugation. The inset shows a TEM micrograph of 31 nm citrate-
stabilized AuNPs (scale bar is 100 nm). 
 
3.2.2 AuNP Functionalization 
Before peptide functionalization, the citrate-stabilized AuNPs were coated with 
polyethylene glycol (PEG) to prevent nonspecific interactions in the physiological 
environment.
2
 A 1.0 mM solution of mPEG-SH (MW 5000, Lysan Bio, Inc.) in deionized 
(DI) water was added for a ~30% surface coverage. The PEG-AuNP solution was left 
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shaking overnight at room temperature and unbound PEG was removed by centrifugation 
(6000 rpm, 14 min). PEG-AuNPs were redispersed in DI water and characterized via 
UV–Vis spectroscopy (Figure 3.1). 
Nuclear-targeted AuNPs (NT-AuNPs) were then functionalized by adding RGD 
and nuclear localization sequence (NLS) peptides to the PEG-AuNPs following a 
previously established method.
3
 Briefly, 5.0 mM solutions of NLS 
(CGGPKKKKRKVGG) in DI water and RGD (CGPDGRDGRDGRDGR) in DI water 
were added to the PEG-AuNPs.  A total of 4,000 peptides per PEG-AuNP were added at 
a 10:1 molar ratio of NLS/RGD peptides. The NT-AuNP solution was shaken overnight 
at room temperature and excess peptides removed by centrifugation (6000 rpm, 14 min). 
The desired AuNP concentration was achieved by diluting stock NT-AuNPs in cell 
culture medium. 
3.2.3 Cell Culture 
Human oral squamous carcinoma (HSC-3) cells, a malignant epithelial cell line 
with αvβ6 integrins overexpressed on the cell membrane, were chosen as our cancer cell 
model.
4
 The cells were cultured in Dulbecco's modification of Eagle's medium (DMEM, 
Mediatech) supplemented with 10% v/v fetal bovine serum (Mediatech), 1% v/v 
antimycotic solution (Mediatech), and 4.5 g/L glucose, L-glutamine, and sodium 




3.2.4 Cell Cycle Analysis 
Cells were grown in culture medium for 24 h and then incubated with 0.1 nM or 
0.2 nM solutions of NT-AuNPs in DMEM. After 24 h of incubation, cells were fixed 
with cold ethanol   (-20°C, 95%) until analysis. For flow cytometric analysis, suspensions 
of fixed cells were centrifuged for 10 min at 2000 rpm and redispersed in PBS. Cells 
were then incubated with 200 μg/mL RNAse (Sigma-Aldrich) at 37°C for 30 min. 
Propidium iodide (100 μg/mL, Sigma-Aldrich) was used to stain DNA for 15 min at 
room temperature. A BD LSR II (BD Biosciences) flow cytometer was used for analysis 
with a 488 nm excitation laser and fluorescence intensity detected in the PE channel. The 
cell cycle data was analyzed using FlowJo software (Tree Star, Inc.). 
3.2.5 Cell Viability Assays 
To determine the cell viability, HSC-3 cells were grown in 96-well plates for 24 h 
and then pretreated with 0.1 nM NT-AuNPs in DMEM. The AuNP solutions were then 
replaced with 100 μM solutions in DMEM of cisplatin (Sigma-Aldrich), camptothecin 
(Sigma-Aldrich), or 5-fluorouracil (5-FU, Sigma-Aldrich). After the desired treatment 
times of 0, 12, 24, 48, and 72 h, the drug solutions were replaced with an XTT solution 
(Biotium, Inc.) in DMEM. Cell viabilities were measured after 4 h on a Biotek Synergy 
H4 Multi-Mode Plate Reader. Absorbance measurements were taken at 450 nm and 690 
nm. To determine the time profile for each drug, the cell viabilities from 3 independent 
experiments were averaged and fit to an exponential function. The ET50 values were 
generated from the fits using OriginPro 9.0 software (Origin Lab, Corp.) and the quality 
of fit for the cisplatin, camptothecin, and 5-FU curves were R
2
 = 0.976, R
2




 = 0.981, respectively. The CDE factors are given as the ratios of the ET50 values of 
camptothecin or 5-FU, relative to cisplatin.  
3.2.6 PERSIS Technique and Anti-Cancer Drug Treatment 
The PERSIS system is composed of a home-made live cell incubator, a dark-field 
microscope, and a spectrometer (USB2000+, Ocean Optics). To obtain Rayleigh 
scattering spectra, cells were grown overnight on a glass-bottom culture dish (MatTek) in 
DMEM. The growth media was then removed and the cells pretreated for 24 h with a 
solution of 0.1 nM NT-AuNPs in DMEM. The AuNP solution was then replaced with 
100 μM solutions of the anti-cancer drugs in DMEM and the samples immediately 
moved to the PERSIS live-cell incubator, located on the microscope stage. The incubator 
maintained the cells at 37°C in a humidified atmosphere of 5% CO2. The PERSIS system 
was designed with an angled beam of white light that reached the sample such that 
incident light passed through undetected, and only scattered light was collected into the 
long-distance 40X microscope objective, which allowed for a ~10 μm2 collection area 
resulting in single cell resolution. The spectral signals from the cells were coupled into an 
optical fiber and recorded, and a CCD camera was used to capture the Rayleigh scattering 
images. 
3.2.7 Spectral Analysis 
Scattering spectra were collected and averaged from 10 individual cells at each 
time point, and all experiments were performed in triplicate. Reference scattering spectra 
were taken from a dark area without cells, and subtracted from the Rayleigh scattering 
spectra of treated cells to remove any scattering from the drug/culture medium 
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background. Spectra were then integrated to give the total Rayleigh scattering intensities, 
which were plotted temporally using OriginPro 9.0 software (Origin Lab, Corp.). The 
intensities were fit to a sigmoidal growth curve using a logistic response function, and 
scattering half-times generated from the fit using OriginPro 9.0 software. The quality of 
fit for the cisplatin, camptothecin, and 5-FU curves were R
2
 = 0.98, R
2
 = 0.97, and R
2
 = 
0.93, respectively. The CDE factors using this method are given as the ratios of the 
scattering half-times of camptothecin or 5-FU, relative to cisplatin. 
3.2.8 Statistical Analysis 
All results are expressed as the mean ± s.e.m. of three independent experiments. 
Changes in scattering intensity were compared using a linear regression analysis 
calculator, and the changes were not considered statistically significant (p = 0.2546, 
GraphPad Software, Inc.). Cell cycle changes were compared using unpaired t-tests 
(GraphPad Software, Inc.) and no statistically significant difference was found between 
NT-AuNP treated HSC-3 cells and untreated control cells. 
3.3 Results and discussion 
To monitor the light scattering and morphology of treated cells, AuNPs were used 
as light-scattering probes to enhance the cells’ inherent Rayleigh scattering, allowing for 
greater differentiation between living and dead cells based on their scattering intensities. 
Cells without nanoparticle pretreatment displayed significantly lower scattering 
intensities, leading to diminished differentiation between living and dead cells, and a less 
accurate comparison of drug efficacies. PERSIS experiments were conducted in a live-
cell chamber (Figure 3.2A) to obtain both Rayleigh scattering dark-field images and 
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Rayleigh scattering spectra from single cells incubated with AuNPs. The temporal effect 
of drug treatment was monitored via changes in the scattering spectra following drug 
administration. We have previously shown that the surface chemistry of AuNPs dictates 
their localization within cells and, consequently, is responsible for their observed strong 
light-scattering properties.
9
 Thus, we used nuclear-targeted AuNPs (NT-AuNPs, Figure 
3.1), for their greater light-scattering abilities. Citrate-capped AuNPs were synthesized, 
and their surfaces were modified to contain polyethylene glycol (PEG) to increase 
biocompatibility and prevent nonspecific interactions under physiological conditions.
17-18
 
After PEGylation, arginine-glycine-aspartic acid (RGD) and nuclear localizing sequence 
(NLS) peptides were bioconjugated to the AuNPs’ surfaces (Figure 3.2B). RGD was 
used to increase nanoparticle endocytosis by targeting αβ integrins on the cell 
membrane,
19-20
 while NLS was used to selectively target the AuNPs at the cell nuclei
21-22
 
and to increase scattering by localizing the plasmonic nanoparticles. HSC-3 cells were 
chosen as the model cell line due to the overexpression of αvβ6 integrins on their 
membrane.
23
 To validate our technique, we calculated the time required to reach a half-
maximal increase in scattering intensity, which is indicative of apoptosis. The relative 
drug efficacies obtained using our technique compared favorably to those obtained using 
the commercial XTT cell viability assay. 
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Figure 3.2 (A) Schematic of the PERSIS instrument used to monitor drug efficacy. (B) 
Illustration of the NT-AuNPs used to enhance the Rayleigh scattering. (C) Chemical 
structure of the anticancer drugs used. 
 
3.3.1 Determining Nanoprobe Pretreatment 
The life cycle of a dividing cell has been extensively characterized from the G1-
phase, which includes cell growth and preparation for DNA replication in the 
forthcoming S-phase, through the G2-phase, which comprises the preparation for mitosis 
and the birth of two daughter cells in the M-phase.
24
 To effectively compare the relative 
efficacy of several anticancer drugs, the concentration of AuNP scattering probes must be 
chosen to enhance scattering without affecting normal cellular function (e.g., altering the 
cell cycle) or inducing cell death. Accordingly, flow cytommetry was used to evaluate the 
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cell cycle. As shown in Figure 3.3, no significant changes were observed in the cell cycle 
upon treatment with low concentrations of NT-AuNPs (0.1 and 0.2 nM) relative to the 
untreated control cells. Thus, pretreatment with low concentrations of NT-AuNPs is not 
expected to affect anticancer drug treatment, allowing AuNPs to be used as scattering 
probes for the effective evaluation of relative drug efficacies. Both 0.1 and 0.2 nM NT-
AuNPs gave similar scattering enhancement upon cell death (~50%); therefore, 0.1 nM 
was used for the remaining experiments. 
 
 
Figure 3.3 Cell cycle analysis of HSC-3 cancer cells treated with 0.1 nM (red) and 0.2 
nM (blue) NT-AuNPs for 24 hours. There was no significant difference in the cell cycle 
between the treated cancer cells and the untreated control cells (black). 
 




















3.3.2 Drug Efficacy via Cell Viability Assays 
In order to assess the validity of our PERSIS technique to the current assay 
standard, the efficacies of three popular anticancer drugs, cisplatin, camptothecin, and 5-
FU (Figure 3.2C), were first determined. Efficacy was expressed as the effective time 
needed to induce 50% cell death (ET50) following treatment with the anticancer drugs. 
To mimic the conditions of the PERSIS experiments, cells were first pretreated with 0.1 
nM NT-AuNPs in culture media for 24 h. The AuNP solutions were then replaced with 
100 μM solutions of the anticancer drugs for the desired treatment times. We obtained the 
temporal response of cancer cell viability to anticancer drug treatment over 72 h using an 
XTT cell viability assay (Figure 3.4). These time profiles showed the enhanced efficacy 
of cisplatin (ET50 = 16 ± 1 h) relative to camptothecin and 5-FU, which had ET50 values 
of 52 ± 3 and 67 ± 2 h, respectively. For a simpler comparison between the drugs, we 
used the previously established cell death enhancement (CDE) factor,
25
 which is defined 
as the ratio of the ET50 values of camptothecin or 5-FU relative to cisplatin. Using the 
ET50 values extracted from the curve fits of the cell death time profiles in Figure 3.4, 
CDE factors were calculated to be 3.3 for camptothecin and 4.2 for 5-FU. Additionally, 
treatment with NT-AuNPs alone did not induce any significant cell death (Figure 3.4), 
further indicating that the low concentration of AuNPs served only to enhance Rayleigh 
scattering from the cells, allowing for greater differentiation between dead cells and 
living cells, without affecting cellular function or drug treatment. 
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Figure 3.4 Time profile of HSC-3 cells treated with 100 μM cisplatin (green), 
camptothecin (blue), and 5-FU (teal), shown as the average cell viability ± s.e.m. from 
three independent experiments. ET50 values were calculated to be 16 ± 1 h for cisplatin 
(R
2
 = 0.976), 52 ± 3 h for camptothecin (R
2
 = 0.977), and 67 ± 2 h for 5-FU (R
2
 = 0.981), 
giving CDE factors of 3.3 and 4.2 for camptothecin and 5-FU, respectively. Control cells 
treated with AuNPs alone (red) did not have a significant decrease in viability. 
 
3.3.3 Drug Efficacy via PERSIS Technique 
To compare drug efficacies using our PERSIS technique, cells were pretreated 
with 0.10 nM NT-AuNPs for 24 h to enhance their Rayleigh scattering. The AuNP 
solutions were then replaced with 100 μM solutions of the anticancer drugs, and cellular 
morphology and light scattering were monitored from 10 different cells for 24 h via 
Rayleigh scattering spectra (Figure 3.5) and dark-field images. After drug 
administration, the Rayleigh scattering spectra initially remained constant but increased 

























over time as cell death progressed. As seen in Figure 3.5, cisplatin induced the quickest 
increase in Rayleigh scattering, while 5-FU treatment displayed the slowest scattering 
increase. These trends correlate well with that previously observed using XTT cell 
viability assays. Complete cell death was signified when the spectra remained constant 
and changes were no longer observed. Dark-field images were also taken for the control 
cells that did not receive drug treatment, and cells treated with cisplatin, camptothecin, 
and 5-FU, which allowed the cell death to be observed visually. Upon drug treatment, the 
initially viable cells were seen to first shrink and lose mobility, indicative of apoptosis,
13
 
and then showed a large increase in light scattering due to having more nanoparticles in 
close proximity.
26-27
 Thus, the number of nanoparticles with optimal interparticle 
separation distances increased within the shrunken cells, resulting in greater scattering 
intensities. Eventually, the cell morphology remained constant, and the treated cells 
ceased all movement. It should be noted that the number of visible cells decreased as 
some of the dead cells floated off of the culture dish and out of the focal plane of the 
microscope. HSC-3 cells that did not receive anticancer drug treatment did not exhibit 
these visual or spectral changes (Figure 3.6) and were seen to increase in number due to 
cell cycle proliferation. 
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Figure 3.5 Real-time Rayleigh scattering spectra of HSC-3 cells treated for 24 h with 100 
μM cisplatin, camptothecin, and 5-FU, shown as the mean ± s.e.m. of three independent 
experiments (n = 10 cells). 
 
To quantitatively compare the relative efficacy of the anticancer drugs using the 
PERSIS technique, the time profile of cell death was obtained to correlate the observed 
visual changes and increased light scattering to the biochemically determined cell death 
parameters. The Rayleigh scattering spectra in Figure 3.5 were integrated to obtain the 
total scattering intensity. These intensities, shown in Figure 3.7, were plotted temporally 
to obtain a time profile of cell death based on the increased light scattering from the cells 
















































upon drug treatment. The plasmonically enhanced Rayleigh scattering was found to 
initially remain constant for all of the samples, before a large increase due to cell death. 
However, the scattering profiles changed at different rates, which correlated with the 
differences observed in the ET50 values obtained using the XTT cell viability assay. 
Additionally, NT-AuNP incubated cells that were not treated with anticancer drugs did 
not display any significant changes in scattering over 24 h, as seen in Figure 3.6. To 
effectively compare these changes, scattering half-times, defined as the time required to 
achieve the half-maximal increase in scattering intensity, were calculated for each drug. 
Cisplatin had the fastest scattering half-time of 2.9 ± 0.2 h, followed by camptothecin and 
5-FU with scattering half-times of 8.6 ± 1.6 and 12 ± 0.8 h, respectively (Figure 3.7). 
These scattering half-times are again similar to the trends observed from the 
biochemically determined drug efficacies (Figure 3.5). To directly compare drug 
efficacies as well as compare our PERSIS technique with traditional cell viability assays, 
we calculated CDE factors for the anticancer drugs using the ratio between the scattering 
half-times of camptothecin or 5-FU relative to cisplatin. As shown in  
Table 3.1, the CDE factors for camptothecin (3.0) and 5-FU (4.1) calculated 
using the PERSIS technique compared favorably to those obtained using the XTT cell 
viability assay (3.3 and 4.2, respectively), indicating the ability of PERSIS to accurately 
assess drug efficacy. Moreover, the PERSIS technique, including nanoparticle 
pretreatment, decreased the time required to obtain ET50 values by 24 h. 
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Figure 3.6 (A) Rayleigh scattering spectra of untreated HSC-3 cells after 24 h incubation 
with NT-AuNPs show no change with time. (B) Total Rayleigh scattering intensity of 
untreated HSC cells after 24 h incubation with NT-AuNPs show no statistically 




Figure 3.7 Rayleigh scattering intensity time profiles of HSC-3 cells treated with 100 μM 
cisplatin, camptothecin, and 5-FU, shown as the average intensity ± s.e.m. from three 
independent experiments. Scattering half-times were calculated to be 2.9 h for cisplatin 
(A, R
2
 = 0.982), 8.6 h for camptothecin (B, R
2
 = 0.976), and 12 h for 5-FU (C, R
2
 = 
0.928), giving CDE factors of 3.0 and 4.1, respectively. 
B. A. 
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Table 3.1 CDE Factors Obtained Using the PERSIS Technique, Comparable to Those 













cisplatin 16 ± 1 2.9 ± 0.2   
camptothecin 52 ± 3 8.6 ± 1.6 3.3 3.0 
5-FU 67 ± 2 12 ± 0.8 4.2 4.1 
 
3.4 Conclusion 
In conclusion, we have demonstrated the accuracy of our PERSIS technique for 
determining relative drug efficacies using NT-AuNPs as scattering enhancement probes. 
The model cell line, HSC-3, was pretreated with a low concentration of AuNPs to 
enhance their Rayleigh scattering without affecting normal cellular function or inducing 
cell death. The relative drug efficacies obtained with our technique correspond favorably 
to those obtained using a standard cell viability assay. The PERSIS technique presents a 
novel system for studying the effects of drug treatment based on the morphological 
changes and increase in scattered light observed upon cell death. This represents a 
continuous assay capable of monitoring a single sample of living cells in real time, 
without the need for expensive instrumentation. Furthermore, this home-built system has 
the potential to be engineered into a multicomponent assay capable of screening multiple 
samples simultaneously, which could allow for the rapid comparison of various drugs, or 
drug analogues, against a particular disease or cell line. 
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CHAPTER 4. A REAL-TIME SURFACE ENHANCED RAMAN 
SPECTROSCOPY STUDY OF PLASMONIC PHOTOTHERMAL 
CELL DEATH USING TARGETED GOLD NANOPARTICLES 
[1] 
(Adapted with permission from Aioub, M.; El-Sayed, M. A. A Real-Time Surface 
Enhanced Raman Spectroscopy Study of Plasmonic Photothermal Cell Death Using 
Targeted Gold Nanoparticles. J. Am. Chem. Soc. 2016, 138, 1258-1264. Copyright 2016 
American Chemical Society.) 
Plasmonic nanoparticles are increasingly utilized in biomedical applications 
including imaging, diagnostics, drug delivery, and plasmonic photothermal therapy 
(PPT). PPT involves the rapid conversion of light into heat by plasmonic nanoparticles 
targeted to a tumor, causing hyperthermia-induced cell death. These nanoparticles can be 
passively targeted utilizing the enhanced permeability and retention effect, or actively 
targeted using proteins, peptides, or other small molecules. Here, we report the use of 
actively targeted spherical gold nanoparticles (AuNPs), both to induce PPT cell death, 
and to monitor the associated molecular changes through time-dependent surface 
enhanced Raman spectroscopy within a single cell. We monitored these changes in real-
time and found that heat generated from the aggregated nanoparticles absorbing near-
infrared (NIR) laser light of sufficient powers caused modifications in the protein and 
lipid structures within the cell and ultimately led to cell death. The same molecular 
changes were observed using different nanoparticle sizes and laser intensities, indicating 
the consistency of the molecular changes throughout PPT-induced cell death from 
actively targeted AuNPs. We also confirmed these observations by comparing them to 
reference spectra obtained by cell death induced by oven heating at 100°C. The ability to 
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monitor PPT-induced cell death in real-time will help understand the changes on a 
molecular level and offers us a basis to understand the molecular mechanisms involved in 
photothermal cancer cell death. 
4.1 Introduction 
The use of nanoparticles in biomedical applications has increased tremendously in 
recent years due to their biologically relevant size and the unique chemical, physical, and 
optical properties that arise on the nanoscale. Metallic nanoparticles have been heavily 
used in particular, due to the growing ease of their colloidal synthetic strategies, precise 
control over their size and shape, facile surface chemistry, and tunable optical properties. 
2-6
 Gold nanoparticles (AuNPs) exhibit these properties, along with low inherent toxicity, 
an essential requirement for biological applications.
7
 They also display intense optical 
properties arising from their localized surface plasmon resonance (LSPR).
8
 The LSPR 
arises from the coherent oscillation of electrons in the conduction band, in resonance with 
light of a particular frequency. The observed LSPR peak depends on the dielectric 
function of the metal nanoparticle and surrounding media, as well as the size and shape of 
the nanoparticle.
8,9
 Therefore, the LSPR can easily be tuned for biological applications by 
adjusting the size and shape of the nanoparticles to control the observed wavelength and 
relative scattering/absorption properties.
9,10
 This has led to the widespread use of AuNPs 
in cellular imaging (including both surface enhanced Raman scattering (SERS) for 





 and plasmonic photothermal therapy (PPT).
16,17
 
PPT is a promising cancer treatment where plasmonic nanoparticles rapidly 
convert NIR light to heat through the nonradiative relaxation of the excited LSPR 
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through electron–electron, electron–phonon, and phonon–phonon collisions. These 
interactions generate an intense heating of the gold nanoparticle, leading to the 
hyperthermia induced death of cells in close proximity to the nanoparticles.
10,16,18
 
Therefore, PPT relies on the accumulation of plasmonic nanoparticles in or around the 
cells of interest, which can be achieved through passive- or active-targeting.
19
 AuNPs can 
be passively targeted to tumors through the enhanced permeability and retention (EPR) 
effect, which occurs due to the abnormal vasculature that results from tumor angiogenesis 
and results in the accumulation of nanoparticles and small molecules at the tumor site.
20
 
Nanoparticles can also be actively targeted to cancer cells using proteins, peptides, or 
small molecules, such as antiepidermal growth factor receptor or herceptin proteins, or 
RGD peptides, which target overexpressed receptors on the cancer cell surface.
21
 
Significant research efforts have gone into characterizing cell death resulting from PPT 
treatment, and investigating specific proteins and signaling molecules, as well as the 
mechanisms underlying cell death (i.e., apoptosis or necrosis).
16,18,22,23
 However, there 




 cell death 
resulting from PPT. These conflicting reports are most likely due to differences in the 
nanoparticle targeting (passive or active), physical properties (e.g., size, shape, absorption 
cross section, etc.) that dictate the absorption cross section, spectral overlap between the 
plasmon band and the laser used for PPT, and the intensity and duration of the laser 
exposure. 
In the present work, we exploit the enhanced optical properties of AuNPs, 
namely, their strong absorption properties to induce PPT cell death, and their intense 
scattering to monitor the molecular changes that occur in real-time using SERS. While 
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Raman scattering is a relatively old technique, the advent of enhanced Raman 
spectroscopies, such as SERS, has resulted in incredible enhancement factors of up to 
10
14
, making single molecule and single cell spectroscopies achievable.
28,29
 Here, we 
have used actively targeted AuNPs and SERS to study PPT-induced cell death in real-
time, as a function of both nanoparticle concentration and laser intensity. Because SERS 
enhancement is only observed in the AuNP microenvironment, we are able to follow the 
molecular changes that occur around the nanoparticles as heat is generated in real-time. 
We found a minimum threshold of laser intensity/nanoparticle concentration, below 
which heat dissipation outpaces heat generation and no cell death is observed. When 
above this threshold, the heat generated causes perturbations to lipid and protein 
structure, ultimately resulting in cell death. Increasing laser intensity leads to more rapid 
cell death, but the same biochemical changes are observed.  
4.2 Methods 
4.2.1 Materials 
Tetrachloroauric acid trihydrate (HAuCl4·3H2O) and trisodium citrate were 
purchased from Sigma-Aldrich. Methoxy-poly(ethylene glycol)-thiol (mPEG-SH, MW 
5000) was obtained from Laysan Bio, Inc. Custom RGD (RGDRGDRGDRGDPGC) and 
NLS (CGGGPKKKRKVGG) peptides were purchased from GenScript, Inc. Dulbecco’s 
phosphate buffered saline (PBS), Dulbecco’s modified Eagle’s medium (DMEM), 
antibiotic solution, fetal bovine serum (FBS), 0.25% trypsin/2.2 mM EDTA, and 
propidium iodide (PI) were purchased from VWR. Annexin-V binding buffer was 
obtained from Invitrogen, Inc., and Annexin-V FITC was purchased from Biolegend. 
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4.2.2 Instrumentation 
Transmission electron microscope (TEM) images were taken using a JEOL 
100CX-2 microscope. Average nanoparticle particle diameter was measured using 
ImageJ software. UV–vis spectra were collected using an Ocean Optics HR4000CG-UV-
NIR spectrometer. Dark-field images and SERS spectra were collected using a Renishaw 
InVia Raman microscope coupled with a Leica optical microscope and 785 nm diode 
Raman excitation laser. Flow cytometry experiments were performed using a BD LSR II 
Flow Cytometer (BD Biosciences).  
4.2.3 Larger AuNP (30 nm) Synthesis and Functionalization 
Citrate-capped gold nanoparticles (AuNPs) were prepared following the 
Turkevich/Frens citrate reduction technique.
30,31
 A 100 mL aqueous solution of 0.60 mM 
chloroauric acid was heated with stirring. Just before the solution reached boiling, 1 mL 
of 90 mM sodium citrate was added. Stirring and heating were discontinued and the 
solution was allowed to cool to room temperature when a red-wine color was observed. 
The citrate-stabilized AuNPs were first cleaned by centrifugation at 4000g for 15 
min and redispersed in deionized (DI) water. The AuNPs were then conjugated with PEG 
to increase stability, enhance biocompatibility, and prevent nonspecific interactions in 
physiological environments.
21
 A 1.0 mM solution of mPEG-SH in DI water was added to 
achieve a ~20% surface coverage. The PEG-AuNP solution was shaken at room 
temperature overnight and unbound ligands removed by centrifugation (12000g, 7 min). 
PEG-AuNPs were again dispersed in DI water, followed by conjugation with a 1:10 ratio 
of RGD and NLS peptides to fill remaining surface sites. The AuNPs were centrifuged 
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(12000g, 7 min) to remove unbound peptides and dispersed in DI water to yield nuclear 
targeted gold nanoparticles (NT-AuNPs). 
4.2.4 Smaller AuNP (sAuNP) Synthesis and Functionalization 
Smaller citrate-capped gold nanoparticles (sAuNPs) were also prepared following 
the Turkevich/Frens citrate reduction technique.  A 100 mL aqueous solution of 0.25 mM 
chloroauric acid was heated with stirring.  Just before the solution reached boiling, 2 mL 
of 65 mM trisodium citrate was added.  Stirring and heating were discontinued and the 
solution was allowed to cool to room temperature when a red-wine color was observed. 
The sAuNPs were first cleaned by centrifugation at 9500g for 15 min and 
redispersed in deionized (DI) water.  The AuNPs were then conjugated with PEG to 
increase stability, enhance biocompatibility, and prevent nonspecific interactions in 
physiological environments.  A 1.0 mM solution of mPEG-SH in deionized (DI) water 
was added to achieve a ~20% surface coverage.  The PEG-AuNP solution was shaken at 
room temperature overnight and unbound ligands removed by centrifugation (12500g, 10 
min).  PEG-sAuNPs were again dispersed in DI water, followed by conjugation with a 
1:10 ratio of RGD and NLS peptides to fill remaining surface sites.  The AuNPs were 
again centrifuged (12500g, 10 min) to remove unbound peptides and dispersed in DI 
water to yield the smaller nuclear targeted gold nanoparticles (NT-sAuNPs). 
4.2.5 Cell Culture 
Human oral squamous carcinoma (HSC-3) cells, an epithelial cell line expressing 
αβ integrins on the cellular membrane,
32
 were used as our cancer model. The cells were 
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cultured in DMEM supplemented with 10% v/v FBS and 1% v/v antibiotic. Cell cultures 
were maintained in a 5% CO2 atmosphere in a humidified 37°C incubator.  
4.2.6 Apoptosis–Necrosis Assay 
Cells were seeded in culture medium for a 70% final confluence and allowed to 
adhere overnight.  The growth media was then removed and the cells were incubated with 
0.10 nM NT-AuNPs in DMEM for 24 h.  After nanoparticle incubation, the NT-AuNP 
solution was replaced with DMEM and cells to be heated were placed in a 100°C oven 
for 7 min to induce cell death.  For flow cytometric analysis, cells were trypsinized for 7 
min and collected via centrifugation (7 min, 250g).  Cells were washed twice with cold 
PBS and redispersed in 500μl Annexin V binding buffer.  Cells were then incubated with 
5 μl of Annexin V-FITC and 2 μl of PI (100μg/ml) for 15 min at room temperature.  
Following incubation, 493 μl of Annexin V binding buffer was added and the samples 
were immediately analyzed via flow cytometry.  Fluorophores were excited with a 488 
nm laser and detected by a 525/30 BP filter for FITC and a 575/30 BP filter for PI.  
Sample populations consisted of at least 10000 events and results were analyzed using 
FlowJo software (TreeStar, Inc.). 
4.2.7 SERS Measurements 
For SERS studies, cells were seeded on round glass coverslips for a 70% final 
confluence. After cells were allowed to adhere overnight, the cells were incubated with 
NT-AuNPs diluted to the specified concentrations in complete DMEM for 24 h. NT-





Following nanoparticle incubation, single cells were irradiated for 2 h using the 
785 nm diode laser at the indicated intensities. Time-dependent SERS spectra were 
recorded throughout the laser exposure to monitor the molecular changes upon 
photothermal heating of the NT-AuNPs. These spectra were collected from the area 
within the cell that displayed the most scattering due to nanoparticle localization, 
corresponding to the areas with the greatest enhancement of Raman vibrations from 
molecules in the nanoparticle microenvironment.  The laser was directed into the 
microscope and focused on the sample by a 50×/0.75 N.A. objective, leading to a ~1–2 
μm spot size and resulting in single cell irradiation/resolution. For oven heating 
experiments, SERS spectra were obtained and averaged from 10 individual cells before 
and after heating. All SERS measurements were obtained in supplemented DMEM 
without phenol red. SERS spectra were measured in backscattering geometry using a 
1200 lines/mm grating and collected by a CCD detector in the 400–1800 cm
−1
 range with 
a 10 s integration time. Spectra were background corrected using a cubic spline 
interpolation for the baseline fit by manually selecting points representative of the 
background. Dark-field images were collected using a Lumenera infinity2 CCD camera. 
4.3 Results and Discussion 
Plasmonic photothermal therapy (PPT) is increasingly being investigated as a 
cancer therapy using gold nanoparticles (AuNPs) to absorb NIR light and rapidly produce 
heat, causing hyperthermia in the nanoparticle vicinity. However, differences in the size 
and shape of the nanoparticles lead to different absorption and scattering properties,
9,10
 
impacting the amount of heat generated and influencing the mechanism of cell death. 
Active nanoparticle targeting with proteins or cell-penetrating peptides (CPPs) and 
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passive-targeting through the EPR effect results in nanoparticle accumulation (and 
therefore heat generation) either within individual cells, or within the tumor 
microenvironment, respectively. For this study, we have used actively targeted AuNPs 
due to their strong absorption properties leading to PPT-induced cell death, and their 
intense plasmonic field, allowing the monitoring of the SERS spectra for biochemical 
changes of the nanoparticle environment throughout the laser treatment and 
accompanying cell death. 
Nearly spherical AuNPs were synthesized following the Turkevich/Frens citrate 
reduction method, where the gold salt precursor is reduced via sodium citrate, which also 
acts as the capping agent to complete nanocrystal growth. The AuNPs were characterized 
by TEM (Figure 4.1B) and found to have a ~29±3 nm diameter and an LSPR peak at 529 
nm. The citrate-capped AuNPs were then conjugated with mPEG-SH to increase their 
stability and biocompatibility, and with RGD and NLS peptides, to promote cellular 
uptake
34
 and localization at the nuclear region,
35
 respectively. Successful conjugation is 
evident in the red-shift of the plasmon peak to longer wavelengths, from 529 nm for the 
as-synthesized AuNPs to 531 nm for PEG-AuNPs, and finally to 533 nm for the NT-
AuNPs (Figure 4.2A). Cancer cells were then incubated with NT-AuNPs for 24 h to 
allow for uptake into the cells and localization at the nuclear region, which was 
confirmed through dark-field microscopy (Figure 4.1C). Localization of the AuNPs was 
critical, as it has been widely shown that having multiple AuNPs in close proximity shifts 
the observed LSPR peak to longer wavelengths due to coupling of their plasmonic 
fields.
11,36,37
 This plasmonic coupling allows for the overlap with the 785 nm laser used 
for PPT heating and SERS measurements in this study. The AuNP treatment 
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concentration (0.2 nM) was specifically chosen to allow for significant heat generation, 
resulting in PPT-induced cell death, while simultaneously monitoring the SERS spectra 
to identify the biochemical changes resulting from PPT. Following AuNP incubation, 
SERS spectra were collected from single cells for 2 h during continuous laser irradiation, 





Figure 4.1 (A) Schematic showing nuclear-targeted AuNPs (NT-AuNPs) used in this 
study. (B) TEM micrograph of 29 nm citrate stabilized AuNPs. (C) Dark-field image of 
HSC-3 cells incubated with NT-AuNPs, showing the nanoparticles primarily localized at 













Figure 4.2 Characterization of nuclear-targeted AuNPs (NT-AuNPs).  UV-Vis extinction 
spectrum of AuNPs before (black) and after conjugation with PEG (red), and RGD and 
NLS peptides (blue) in aqueous solution. The red shift in the plasmon peak indicates 
successful conjugation. 
 
Initially, SERS bands appeared at ~500 and 654 cm
−1
 (Figure 4.3) primarily 
corresponding to –S–S– and –C–S– vibrations, respectively, from sulfur containing 
amino acids in proteins surrounding the AuNPs.
38,39
 During 6.2 mW laser exposure, the –
S-S- band disappeared almost entirely, indicating the likely rupture of disulfide bonds,
40
 a 
critical component of protein structure, around the AuNPs due to PPT heating. By 
comparison, the intensity of –C–S– vibration band remained relatively unchanged, 
indicating the continued presence of sulfur containing amino acids in the AuNP 
microenvironment. The slight changes in –C–S– vibration intensity could potentially be 
attributed to fluctuations in the interactions of the sulfur containing amino acids and the 
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AuNP plasmonic field, and modifications in their dihedral angles as the amino acids 





Figure 4.3 Time-dependent SERS spectra collected from a single HSC-3 cell during PPT 
cell death induced by continuous laser exposure at lower power (6.2 mW). The vertical 
line at 1225 cm
−1
 serves as a visual guide to highlight the shift in this vibrational peak 
from the amide III β-confirmation at 1225 cm
−1
 to the aromatic amino acid residue peaks 
at 1209 cm
−1
, which in conjunction with the disappearance of additional vibrations 
around 500 cm
−1
 and in the 1250 cm–1350 cm
−1 
range signals cell death. Corresponding 
dark-field images for each spectrum are shown. 
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Additionally, the Raman band observed at 1225 cm
−1
 in the initial spectra is 
mainly attributed to the amide III vibration of the β-sheet conformation of the 
proteins.
42,43
  Upon laser exposure, this band shifted toward 1209 cm
−1
, which is 
primarily due to the C6H5–C stretch of phenylalanine (with some contribution from 
tyrosine).
44
 This was accompanied by the enhancement of the intensity of the 1180, 1001, 
and 1584 cm
−1





 and in-plane CH stretching vibrations corresponding to phenylalanine 
moieties,
44,45,48
 respectively.  While fairly weak in the initial SERS spectra, these bands 
were seen to grow progressively stronger in intensity, eventually dominating the spectra 
along with the 1209 cm
−1
 vibration. Furthermore, additional spectral bands were seen at 
~835 cm
−1
 due to symmetric lipid–O–C–C–N– stretches and tyrosine,
49,50
 and at 1130 
cm
−1
, due to lipid trans-confirmations and the C–N backbone of proteins,
51-53
 
respectively. Additional vibrations are also observed in the 1275–1350 cm
−1
 region, 
attributed to the amide III vibrations of α-helix and random coil structures in the 
surrounding proteins,
53-55
 as well as the –CH2 twist in lipids.
50,53,56
 Upon PPT heating, 
these protein and lipid structural vibrations disappeared, further supporting the hypothesis 
that, during laser exposure, actively targeted AuNPs generate intense amounts of local 
heat within the cell, disrupting lipid and protein structure and ultimately resulting in 
hyperthermia-induced cell death. Since the targeting peptides conjugated to the AuNPs do 
not contain phenylalanine, tryptophan, or tyrosine, the observed spectral features must 
originate from proteins within the cells. A detailed assignment of these spectral bands can 
be found in Table 4.1. 
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These spectral changes suggest a clear modification in protein confirmation 
within the cells during PPT heating. It is likely that the local heat induced by the 
plasmonic excitation could perturb/denature the conformation of the protein corona 
around the nanoparticles as well as in their surrounding microenvironment so as to 
expose the hydrophobic amino acid residues to the nanoparticle plasmonic field.
57
 The 
appearance of Raman vibrations mainly corresponding to phenylalanine after laser 
exposure (beginning around 5 min and steadily increasing) strongly supports this 
hypothesis. Combined with the reduction in the intensity of vibrations corresponding to 
the disulfide (–S–S–) bonds appearing around 500 cm
−1
, these features suggest rupturing 
of the disulfide bonds induced by the plasmonic heating. This is further support for 
protein denaturation in the AuNP microenvironment as these aromatic amino acids are 
highly hydrophobic and generally found buried within proteins,
58
 shielding them from 
solvent exposure and, accordingly, from the plasmon field of the hydrophilic AuNPs. 
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Table 4.1 Assignment of SERS Spectral Bands 
shift (cm
−1
) component SERS band assignment 
495-510 protein –S–S– 
640-660 protein –C–S– 
820-850 lipid and protein  lipid symmetric –O–C–C–N– 
stretch and Tyr 
1000-1010 protein Phe ring breathing 
1020-1030 protein Phe C–H in-plane bending and 
Trp ring breathing 
1120-1140 lipid and protein C–N backbone and Lipid trans-
conformations 
1170-1190 protein C–H bend, C–C stretch, Tyr 
1200-1210 protein C6H5–C stretch of Phe and Tyr 
1215-1225 protein Amide III (β-sheet) 
1265-1300 protein Amide III (α-helix) 
1300-1325 protein & lipid –CH2 twist 
1440-1460 protein & lipid –CH2 bending (protein and lipid) 
and methylene deformation  
1584-1592 protein Phe 
 
 
The spectral changes resulting from PPT cell death noted above are seen in cells 
treated with 0.20 nM NT-AuNPs and exposed to the laser operating at both 6.2 mW 
(Figure 4.3) and 9.4 mW (Figure 4.4) intensity. While the initial and final spectra are 
similar in both cases, exposure to a higher laser intensity resulted in faster loss of protein 
structure, evident in the more rapid loss of the disulfide peak at ~500 cm
−1
, the exposure 
of phenylalanine residues at 1001 cm
−1
, and the increase in amide III β-sheet vibration 
 129 
(along with Phe, Tyr, and lipid contributions) in the 1200–1220 cm
−1
 region, relative to 
the amide III α-helix vibrations in the 1275–1300 cm
−1
 region (Figure 4.5). These ratios 
illustrate the drastic changes that occur during PPT-induced cell death. With more intense 
laser exposure, these changes began immediately and occurred rapidly, following an 
exponential trend. This implies that, at high enough laser intensity (9.4 mW), protein and 
lipid structural features begin to denature upon laser exposure. However, at the 
intermediate intensity (6.2 mW), an induction period was observed. Initially, the 
structural changes occur very slowly, but begin to increase over time, following a 
sigmoidal trend commonly observed in dose response studies. This implies that at this 
intermediate laser intensity, heat is generated slightly faster than it dissipates, leading to a 





Figure 4.4 Time-dependent SERS spectra collected from a single HSC-3 cell during PPT 
cell death    induced by continuous laser exposure at higher power (9.4 mW). The vertical 
line at 1225 cm
−1
 again serves as a visual guide to highlight the shift in this vibrational 
peak from the amide III β-confirmation to the aromatic amino acid residue peaks at 1209 
cm
−1
, which in conjunction with the disappearance of additional vibrations around 500 
cm
−1
 and in the 1250–1350 cm
−1 
range signals cell death. Corresponding dark-field 
images for each spectrum are also shown. 
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Figure 4.5 Plot showing changes in the SERS intensities for the ratio of the –S–S– and   
–C–S– vibrations (A), 1000 and 1130 cm
−1
 vibrations (B), and amide III β and α 
confirmations (C) during PPT heating at the indicated laser powers (n=4 cells). 
 
Additionally, at lower laser intensity (2.6 mW, Figure 4.6) or lower NT-AuNP 
concentration with higher laser intensity (0.10 nM, 9.4 mW, Figure 4.7), these spectral 
changes were not observed, and the ratios in Figure 4.5 remain relatively unchanged. 
This indicates that there is a critical threshold of nanoparticle concentration and laser 
intensity (i.e., of heat) necessary to generate PPT-induced cell death. Below this 
threshold, heat is most likely dissipated more rapidly than it is generated, and no major 
spectral changes or cell death is observed. However, when the laser intensity and 
nanoparticle concentration are above this threshold, heat generation outpaces heat 
dissipation, which results in PPT-induced cell death. It should be noted that this critical 
threshold for cell death is likely dictated by the number of nanoparticles internalized 
within the cell and degree of localization, which depends on their surface chemistry and 
the AuNPs absorption properties, which are primarily dictated by the size, shape, and the 
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Figure 4.6 Time-dependent SERS spectra collected from a single HSC-3 cell incubated 
with 0.20 nM NT-AuNPs showing no PPT cell death induced by continuous laser 
exposure at lower power (2.6 mW).  The vertical line at 1225 cm
−1
 highlights the 
vibrational peak from the amide III β-confirmation, which does not shift during laser 
exposure at low power, indicating a lack of cell death.  Corresponding dark-field images 
for each spectrum are also shown. 
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Figure 4.7 Time-dependent SERS spectra collected from a single HSC-3 cell incubated 
with 0.10 nM NT-AuNPs showing no PPT cell death induced by continuous laser 
exposure at higher power (9.4 mW).  The vertical line at 1225 cm
−1
 highlights the 
vibrational peak from the amide III β-confirmation, which does not shift during laser 
exposure when lower nanoparticle concentration is used, indicating a lack of cell death.  
Corresponding dark-field images for each spectrum are shown. 
 
The same spectral changes arising from PPT induced cell death can be observed 
by using smaller (15 nm) AuNPs modified with the same active targeting ligands (NT-
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sAuNPs, Figure 4.8). Cell death is observed after incubation with 0.20 nM NT-sAuNPs 
upon exposure to both the lower (6.2 mW, Figure 4.9) and higher (9.4 mW, Figure 4.10) 
laser intensities previously observed to induce cell death in Figure 4.3 and Figure 4.4 
using the larger 30 nm AuNPs. The initial SERS spectra, as well as the final spectra after 
120 min laser exposure, are nearly identical to those obtained using the larger NT-
AuNPs. The same vibrational peaks are also observed to change throughout the PPT 
heating, including loss of the –S–S– vibration at ~500 cm
−1
, the loss of protein and lipid 
structural features observed at 1130 cm
−1
 and in the 1275 cm
−1
 to 1350 cm
−1
 region, the 
shift of the 1225 cm
-1
 vibration due to amide III β-conformation in the initial spectra 
toward 1209 cm
-1
 vibration of phenylalanine, and the drastic increase in aromatic amino 
acid vibrational peaks at 1180, 1001, and 1584 cm
−1
. The observation of the same 
spectral changes with different laser intensities and different nanoparticle sizes shows the 
reproducibility of this technique to induce and monitor PPT cell death with actively 
targeted AuNPs on the single cell level. This also supports the theory that there is a 
critical threshold of nanoparticle concentration and laser intensity (i.e., photothermal 
energy) necessary to induce cell death, which occurs through the denaturation of proteins 
and lipids in the nanoparticles’ microenvironment. Moreover, using the highly focused 
laser of our Raman microscope results in single-cell irradiation and cell death without 
affecting adjacent cells, as can be clearly seen in Figure 4.11. After incubation with 
either the smaller or larger AuNPs, only the cell of interest displays the distinct 
morphological changes indicative of cell death, including cell shrinkage and increased 
light scattering. Surrounding cells, some within a few microns of the cell being irradiated, 
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appear unchanged even at the highest laser intensity used in this study, confirming the 
single cell specificity of our technique. 
 
 
Figure 4.8 Characterization of smaller nuclear-targeted AuNPs (NT-sAuNPs).  UV–Vis 
spectra of sAuNPs before (black) and after conjugation with PEG (red), and RGD and 
NLS peptides (blue) in aqueous solution. The red shift in the plasmon peak indicates 
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Figure 4.9 Time-dependent SERS spectra collected from a single HSC-3 cell incubated 
with 0.20 nM NT-sAuNPs during PPT cell death induced by continuous laser exposure at 
lower power (6.2 mW).  The vertical line at 1225 cm
−1
 highlights the shift in this 
vibrational peak from the amide III β-confirmation to the aromatic amino acid peaks at 
1209 cm
−1
, which in conjunction with the disappearance of vibrations around 500 cm
-1
 
and in the 1250–1350 cm
−1 
range signals cell death.  Corresponding dark-field images for 
each spectrum are also shown. 
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Figure 4.10 Time-dependent SERS spectra collected from a single HSC-3 cell incubated 
0.20 nM NT-sAuNPs during PPT cell death induced by continuous laser exposure at 
higher power (9.4 mW).  The vertical line at 1225 cm
−1
 highlights the shift in this 
vibrational peak from the amide III β-confirmation to the aromatic amino acid peaks at 
1209 cm
−1
, which in conjunction with the disappearance of additional vibrations around 
500 cm
−1
 and in the 1250–1350 cm
−1 
range signals cell death.  Corresponding dark-field 
images for each spectrum are also shown. 
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Figure 4.11 Representative dark-field scattering images of cells incubated with (A,B) 0.2 
nM NT-AuNPs or (C,D) 0.20 nM NT-sAuNPs before (A,C) and after (B,D) continuous 
laser exposure (2 hours, 9.4 mW).  White arrows denote the cell of interest.  The images 
illustrate the single cell specificity of this method, as only the cell of interest is irradiated 
and displays morphological changes while surrounding cells are relatively unchanged and 
continue to move freely on the coverglass.  The scale bar in each image is 50 μm. 
 
Additionally, cells were incubated with 0.10 nM NT-AuNPs, and SERS spectra 
were collected before (Figure 4.12A) and after (Figure 4.12B) oven heating at 100 °C 
for 7 min. The initial spectra before oven heating were nearly identical to those obtained 
before PPT heating, highlighting the reproducibility of our technique across individual 
cells. The protein and lipid structural vibrations are again observed in the healthy cells 





However, the structural vibrations of both proteins and lipids are no longer seen after 
oven heating, and the aromatic amino acid vibrations again dominate the SERS spectra, 
which were nearly identical to the final spectra obtained after PPT-induced cell death. 
 
 
Figure 4.12 SERS spectra of HSC-3 cells incubated with 0.10 nM NT-AuNPs before (A) 
and after (B) oven heating at 100°C for 7 min. The spectrum shown in part B is 
consistent with those shown in Figure 4.3 and Figure 4.4, displaying characteristics 
attributed to cell death. 
 
To confirm cell death, we also performed flow cytometric analysis on cells 
incubated with 0.10 nM NT-AuNPs before (Figure 4.13A) and after oven heating 
(Figure 4.13B). A PI dye was used to tag necrotic cells, which have diminished 
membrane integrity, allowing the otherwise membrane impermeable dye to enter the 
necrotic cells. A FITC conjugated Annexin-V antibody was used to differentiate apoptotic 
cells due to its strong affinity for phosphatidylserine serine, a phospholipid found on the 
outer membrane of apoptotic cells. The HSC-3 cancer cells incubated with 0.10 nM NT-




































over 95% of the cells were undergoing necrosis/late apoptosis, as evidenced by the large 
increase in fluorescence intensity from both the PI and FITC dyes, confirming cell death. 
The similarity between the SERS spectra of oven heated cells and the PPT treated cells, 
combined with the observed morphological changes in those cells, confirms the death of 

























































Figure 4.13 Flow cytometry data showing cells incubated with 0.10 nM NT-AuNPs are 
over 90% healthy before oven heating (A); after oven heating (B), over 95% of cells 
exhibit late apoptosis/necrosis as evidenced by the increase in both FITC and PI 
fluorescence. 
4.4 Conclusion 
We have used actively targeted AuNPs to induce PPT cell death upon laser 
exposure, and simultaneously monitor the corresponding molecular changes in real-time 
using SERS. We have found that continuous laser exposure of actively targeted 
nanoparticles internalized within cells leads to the modification of the protein and lipid 
structures, resulting in cell death. These alterations occur when the nanoparticle 
concentration/laser intensity (photothermal energy) reaches a minimum threshold. Above 
this critical point, cell death occurs through the same molecular changes, regardless of the 
nanoparticle size or laser intensity. It is important to note that cell death may still occur 
below this threshold, although not on the time scales studied herein. Additionally, the use 
of passively targeted nanoparticles would most likely result in different cell death 
mechanisms, as heat would be generated in the extracellular matrix surrounding the cell 
instead of from localized hotspots within it. Understanding the molecular mechanism of 
PPT cell death is crucial to understanding the treatment and optimizing its efficacy. We 
have presented a method to both induce and monitor this mechanism within single cells 
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CHAPTER 5. PLATINUM-COATED GOLD NANORODS: 
EFFICIENT REACTIVE OXYGEN SCAVENGERS THAT 
PREVENT OXIDATIVE DAMAGE TOWARD HEALTHY, 
UNTREATED CELLS DURING PPT 
[1] 
(Adapted with permission from Aioub, M.; Panikkanvalappil, S. R.; El-Sayed, M. A. 
Platinum-Coated Gold Nanorods: Efficient Reactive Oxygen Scavengers That Prevent 
Oxidative Damage toward Healthy, Untreated Cells During Plasmonic Photothermal 
Therapy. ACS Nano 2017, 11, 579-586. Copyright 2017 American Chemical Society.) 
As a minimally invasive therapeutic strategy, gold nanorod (AuNR) -based 
plasmonic photothermal therapy (PPT) has shown significant promise for the selective 
ablation of cancer cells. However, the heat stress experienced by cells during the PPT 
treatment produces significant amounts of reactive oxygen species (ROS), which could 
harm healthy, untreated tissue near the point of care by inducing irreversible damage to 
DNA, lipids, and proteins, potentially causing cellular dysfunction or mutation. In this 
study, we utilized biocompatible Pt-coated AuNRs (PtAuNRs) with different platinum 
shell thicknesses as an alternative to AuNRs often used for the treatment. We show that 
the PtAuNRs maintain the efficacy of traditional AuNRs for inducing cell death while 
scavenging the ROS formed as a byproduct during PPT treatment, thereby protecting 
healthy, untreated cells from indirect death resulting from ROS formation. The 
synergistic effect of PtAuNRs in effectively killing cancer cells through hyperthermia 
with the simultaneous removal of heat stress induced ROS during PPT was validated in 
vitro using cell viability and fluorescence assays. Our results suggest that the high 
photothermal efficiency and ROS-scavenging activity of PtAuNRs makes them ideal 
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candidates to improve the therapeutic efficacy of PPT treatment while reducing the risk 
of undesired side effects due to heat-stress-induced ROS formation. 
5.1 Introduction 
As biomedical applications of nanoparticles have increased greatly in recent 
years, plasmonic photothermal therapy (PPT)
2-3
 has emerged as an effective and 
minimally invasive strategy to selectively target and kill malignant cells. PPT involves 
the delivery of plasmonic nanomaterials to the cancerous cells, where they absorb light 
and convert it into heat, greatly increasing the temperature at the nanoparticles’ surface 
and within the local tumor microenvironment.
4-5
 Gold nanoparticles (AuNPs) are among 
the most heavily studied PPT materials due to their strong optical absorption properties, 
the variety of chemical synthetic methods to produce well-controlled sizes and shapes, 
and their relatively low toxicity.
6-9
 These properties have also led to many biomedical 









 in addition to PPT
20-22
 and photodynamic therapy, which often 
combines PPT with the use of photosensitizing agents or drugs.
23-24
 
The optical properties of gold nanostructures arise from their localized surface 
plasmon resonance (LSPR), which can be easily tuned by adjusting the size and shape of 
the nanoparticle.
25-27
 Significant efforts have gone into synthesizing nanoparticle 









 NIR absorption is highly desirable as 
biological tissue, specifically water and hemoglobin, display minimal light absorption 
within this region of the electromagnetic spectrum, often referred to as the “NIR 
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(biological) window”. Gold nanorods (AuNRs), in particular, are considered an excellent 
candidate for PPT as they display an inherently high absorbance–to–scattering ratio, a 
prerequisite for efficient photothermal conversion, and their LSPR band is easily tunable 
for NIR absorption by simply adjusting the silver content during their synthesis.
2-3, 5, 33
 
Despite the increasing utility of PPT as an effective cancer treatment, the 
interplay between thermally induced cell death and chemically induced cell death, 
through the formation of reactive oxygen species (ROS) during PPT treatment, has not 
been well studied. Oxidative stress has increasingly been implicated as a component of 
numerous degenerative diseases (e.g. Alzheimer’s, autoimmune diseases such as RA, 
etc.) as well as progressive diseases such as cancer.
34-35
 It has also been established that 
ROS can be produced in response to heat stress and during PPT treatment.
36-39
 While 
ROS play a crucial role in endogenous processes, such as cell signaling and 
proliferation,
40
 ROS can also potentially interact with neighboring healthy tissues, 
causing irreversible damage to DNA, proteins and lipids, leading to dysfunction and 
unwanted, off-target cell death.
41-42
 Thus, introducing additional features to current PPT 
materials to maintain efficacy while minimizing potential side effects from ROS 
mediated cell death is highly desirable. 
In this work, we address the utility of platinum-coated gold nanorods as a material 
for efficient PPT in cancer treatment that induces thermal cell death while simultaneously 
scavenging ROS. Platinum is one of the most common metals used to catalyze the 
reduction of oxygen, with applications ranging from fuel cells to the decomposition of 
peroxides. Platinum nanoparticles are also well-known for their antioxidant activity.
43-46
 
As a catalyst for oxygen reduction, a high surface-to-volume ratio is highly desirable to 
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maximize activity while minimizing metal loading. To this end, we synthesized small 
AuNRs and coated the tips with thin platinum shell layers following the method 
developed by Liz-Marzan et al.
47-48
 Platinum-coated AuNRs (PtAuNRs) were 
synthesized with two different shell thicknesses to compare the effect of increasing 
platinum concentration on their biocompatibility and ability to scavenge ROS to reduce 
the potentially harmful side effects of the reactive oxygen species on healthy, untreated 
cells. Conjugation of poly(ethylene) glycol to the nanorods (NRs) mitigated their 
cytotoxicity and allowed for passive targeting of the nanocrystals. We also show that all 
NR compositions induce significant PPT cell death upon short, 1 min irradiation with an 
808 nm NIR continuous wave (cw) laser. Within 30 s of irradiation, the temperature of all 
NR-containing solution surpassed 46°C, the temperature necessary to induce 
hyperthermia-mediated cell death.
49
 The Pt shells successfully scavenged the ROS 
produced in response to the heat stress during PPT treatment. Upon addition of the PPT-
treated media to healthy, untreated control cells, the solutions with PtAuNRs or without 
any NRs showed no toxicity, while the residual ROS from the AuNR-treated media 
induced cytotoxicity toward the healthy cells. Additionally, while the thicker platinum 
shell reduced ROS in both the laser-treated and untreated samples, the thinner shell did 
not alter basal ROS levels. These studies indicate the efficacy of PtAuNRs to induce 
hyperthermia-mediated cell death during PPT while reducing potential side effects on 






Gold(III) chloride trihydrate (HAuCl4·3H2O), cetyltrimethylammonium bromide 
(CTAB), silver nitrate (AgNO3), ascorbic acid, sodium borohydride (NaBH4), potassium 
tetrachloroplatinate(II) (K2PtCl4), and 2,7-dichlorofluorescein diacetate (DCFDA) were 
purchased from Sigma-Aldrich. Methoxypoly(ethylene glycol)thiol (PEG, MW 5000) 
was purchased from Laysan Bio, Inc. Dulbecco’s phosphate buffered saline (PBS), 
Dulbecco’s modified Eagle’s medium (DMEM), antibiotic/antimycotic solution, fetal 
bovine serum (FBS), and 0.25% trypsin/2.2 mM EDTA were purchased from VWR. The 
XTT cell viability assay kit was purchased from Biotium, Inc. 
5.2.2 Instrumentation 
Transmission electron microscope (TEM) images were taken using a JEOL 
100CX-2 microscope. Average nanoparticle particle diameter was measured using 
ImageJ software. High-angle annular dark-field images and energy-dispersive X-ray 
spectroscopy (EDX) elemental line scans were obtained using an FEI Tecnai F30 TEM. 
UV–Vis spectra were collected using an Ocean Optics HR4000CG-UV-NIR 
spectrometer. Extinction coefficients were determined by inductively coupled plasma-
atomic emission spectroscopy (ICP-AES) on a Varian Vista AX simultaneous 
spectrometer. An 808 nm cw laser (~5 W/cm
2
) was used for PPT-heating experiments. 
The increase in solution temperature with PPT heating was measured by placing a 33 
gauge thermocouple (OMEGA Engineering, Inc.) directly into the solutions. 
Fluorescence measurements were collected using a QuantaMaster 40 fluorimeter (Photon 
 153 
Technology International). Zeta potentials of NR solutions in water were measured using 
a Malvern Zetasizer Nano Z. 
5.2.3 Gold Nanorod Synthesis, Platinum Coating, and Functionalization 
Gold nanorods (AuNRs) were synthesized following the seedless growth method 
by Samal et al.
50
 A growth solution was first prepared with 100 mL of 100 mM CTAB, 
4.25 mL of 10 mM HAuCl4, 625 μL of 10 mM AgNO3, and 675 μL of 100 mM ascorbic 
acid. After mixing, 1 mL of NaBH4 (1 mM) was added and the solution was kept 
undisturbed at 25°C for 4 h. The AuNRs were used as prepared for further Pt coating 
experiments. 
Pt-coated AuNRs (PtAuNRs) were prepared following the synthetic protocol 
developed by Liz-Marzan et al. with slight modification.
47-48
 One milliliter of CTAB (100 
mM) was added to 10 mL of the freshly prepared AuNR solution (~1.5 optical density 
(OD)). Next, 100 μL of 10 mM K2PtCl4 was added, followed by 200 μL of ascorbic acid 
(100 mM). The solution was kept at 40°C for 5 h, which resulted in the formation of 
Pt13Au87NRs (13% Pt, 87% Au as determined by ICP-AES). For Pt20Au80NRs, the 
solution was kept at 40°C for 12 h to obtain NRs with higher Pt content. 
All NR solutions were purified by centrifugation for 10 min at 12000g and 
redispersed in deionized (DI) water twice to remove excess CTAB. The NRs were then 
conjugated with PEG to increase stability and biocompatibility.
51
 A 1.0 mM aqueous 
solution of PEG was added at a 10000:1 molar ratio of PEG/NRs, and the PEG-NR 
solutions were shaken overnight at room temperature. NR solutions were again purified 
by centrifugation and redispersed in DI water, and PEG was added a second time at a 
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10000:1 molar ratio. The PEGylated NRs were centrifuged (12000g, 15 min) to remove 
unbound PEG molecules and dispersed in DI water. 
5.2.4 Cell Culture 
Human oral squamous carcinoma (HSC3) cells were used as our cancer model, 
and human keratinocytes (HaCat) cells were used as a healthy control. The cells were 
cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% v/v 
FBS and 1% v/v antibiotic. Cell cultures were maintained in a humidified 37°C incubator 
with a 5% CO2 atmosphere. 
5.2.5 Photothermal Heating of NR Solutions 
PEG-conjugated NRs (AuNRs, Pt13Au87NRs, or Pt20Au80NRs) were diluted to 
ODs of 0.5 in cell culture media. A 100 μL volume of NR solutions was then added to 96 
well plates to mimic the cellular experiments. The NR solutions were then exposed to the 
808 nm laser for increasing irradiation times and the temperature measured by directly 
placing a thermocouple into the solutions. To ensure uniformity, the initial temperature of 
all solutions was 35 ± 1 °C. Three independent experiments were performed and the 
mean ± s.d. of the thermal responses (over 5 min laser exposure) was fit using an 
exponential function.  
5.2.6 Synthesis of 2,7 -Dichlorofluorescein (DCF):   
DCF was prepared from 2,7-dichlorofluorescin diacetate (DCFDA) by mixing 0.5 
mL of 1.0 mM DCFDA in methanol with 2.0 mL of 0.01 M NaOH. The solution was 
kept at 37°C for 30 min to deacetylate the DCFDA, producing the nonfluorescent 
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dichlorofluorescin (H2DCF). The resultant mixture was then neutralized with 10 mL of 
25 mM NaH2PO4 and stored in the dark at −20°C until use. In the presence of ROS, 
H2DCF is oxidized to the fluorescent DCF molecule. 
5.2.7 Cell Viability Assays and ROS Measurement 
For PPT studies, the HSC3 cells were grown overnight in 96-well tissue culture 
plates. Upon reaching 70% confluence, the growth media was replaced with media 
containing PEG-conjugated NRs (AuNRs, Pt13Au87NRs, or Pt20Au80NRs) at optical 
densities of 0.5. After 1 h of incubation, the cells were exposed to the 808 nm laser for 1 
min. The cells were incubated for another 30 min with the NR solutions and then the 
media was aspirated and replaced with culture media containing the XTT cell viability 
assay solution. The viability of the PPT treated HSC3 cells was then determined 
according to the manufacturer’s protocol. 
Following PPT treatment, the ROS levels in cell culture media were determined 
by incubating HSC3 cells with culture media containing NRs and exposing the samples 
to the NIR laser as previously described. After PPT treatment, the laser treated media was 
removed from the cells and centrifuged at 20000g to pellet the NRs. Then, 300 μL of the 
cell media supernatant solution was added to 100 μL of H2DCF (1 mM) and 1.1 mL of 
PBS. The solutions were incubated in the dark for 30 min at room temperature, and the 
fluorescence of the oxidized DCF was measured using an excitation wavelength of 495 
nm and emission of ~525 nm. 
Finally, the toxicity of the PPT-treated cell culture media on healthy (untreated) 
cells was determined. HaCat cells were seeded in 96 well culture plates for a final 
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confluence of 70% and allowed to adhere overnight. Following PPT treatment of the 
HSC3 cells described previously, the aspirated media was centrifuged at 20000g to 
remove the NRs. The HaCat culture media was then replaced with the aspirated laser-
treated media and incubated for 24 h. The laser-treated media was then replaced with cell 
culture media containing the XTT solution, and the viability of the HaCat cells was 
determined as before. 
5.2.8 Nanorod Uptake Assay 
The % of NRs taken up by HSC3 cells was determined as previously reported.
13
 
Briefly, cells were seeded in 96-well tissue culture plates and allowed to adhere 
overnight. The growth media was then replaced with culture medium containing PEG-
conjugated NRs (AuNRs, Pt13Au87NRs, or Pt20Au80NRs) at optical densities of 0.5. After 
2 h of incubation with the NRs, the nanoparticle culture medium was removed to a new 
microplate and the optical density measured at the LSPR peaks of the NR solutions (768 
nm, 820 nm, or 879 nm). The OD of the NR solutions was then subtracted from that 
initially added to the cell culture to determine cellular uptake and converted to a 
percentage of that initially added. 
5.2.9 Statistical Analysis 
Results are expressed as the average ± standard deviation of 3-5 independent 
experiments. Statistical significance was calculated using a t-test or analysis of variance 




5.3 Results and Discussion 
PPT using AuNPs as NIR light absorbers is increasingly studied as a potential 
cancer therapeutic strategy. The absorbed light is rapidly converted to heat, leading to 
large increases in temperature around the AuNPs, inducing cell death from hyperthermia. 
AuNRs are heavily studied due to their extremely high absorption cross section and 
easily tunable LSPR band, which can be shifted within the NIR by simply adjusting the 
NR aspect ratio (AR). Passive targeting using the enhanced permeability and retention 
(EPR) effect results in accumulation of the AuNRs within tumors.
52
 The AuNRs are then 
exposed to NIR light, the intensity and duration of which, along with the NR optical 
properties (i.e., absorption cross section), dictate the mechanism of cell death from PPT 
treatment. During PPT treatment, significant amounts of ROS are produced, which can 
damage DNA, proteins, and lipids in nearby healthy, untreated cells, resulting in the 
death of healthy tissues. In order to address this issue, we developed a PPT platform 
which utilizes hybrid nanorods prepared by depositing thin Pt shells on the tips of 
AuNRs. We show that PtAuNRs retain similar photothermal properties as the parent 
AuNRs, inducing cell death from hyperthermia, while effectively scavenging the ROS 
that are produced during PPT treatment. We compared the heating efficiency of AuNRs to 
PtAuNRs with increasing shell thicknesses and found that the Pt coating on the AuNRs 
surface did not significantly reduce their photothermal efficiency. Importantly, the 
reduction of ROS produced during PPT treatment mitigates the toxicity of the laser-
treated culture media toward healthy, untreated cells. 
Small AuNRs, generally synthesized through seedless techniques, have previously 
been shown to be more efficient PPT agents than larger NRs synthesized through the 
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more common seeded growth methods.
4
 Accordingly, small AuNRs were synthesized for 
this study using the seedless method reported by Samal et al.
50
 The AuNRs displayed an 
LSPR band at 766 nm (Figure 5.1) with a length of 25.6 ± 4.0 nm and width of 6.9 ± 1.1 
nm (AR of 3.7 ± 0.4), as shown in Figure 5.2A and outlined in Table 5.1. In order to 
investigate the formation of ROS and the role of PtAuNRs in scavenging ROS formed 
during PPT-induced cell death, the tips of the AuNRs were coated with thin Pt shells by 
modifying the method of Liz-Marzan et al. The platinum salt was added to the as-
prepared AuNRs, followed by the reducing agent, ascorbic acid, and the solutions were 




Figure 5.1 Vis–NIR extinction spectra of AuNRs before (yellow) and after coating with 
thin (blue, Pt13Au87NRs) and thick (red, Pt20Au80NRs) platinum shells. 
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 159 
 
Figure 5.2 TEM of (A) AuNRs, (B) Pt13Au87NRs, and (C) Pt20Au80NRs. 
 
 
Table 5.1 Dimensions and Optical Properties of NRs before and after Coating the Tips 



































Addition of Pt to the AuNRs was found to red-shift the LSPR band to longer 
wavelengths while also broadening the band due to the changes in nanorod geometry and 
aspect ratio and the increased dephasing of the plasmon at the Au–Pt interface, 
respectively. Reduction of the Pt salt for 5 h resulted in the growth of a ~1.5 nm thick Pt 
shell on the AuNR tips, increasing the NR length to 28.0 ± 4.1 nm and the width of the 
A B C 
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NR tips to 8.4 ± 1.3 nm (AR = 4.1 ± 0.5). These NRs contained a mole ratio of 13% Pt 
and 87% Au (Pt13Au87NRs), as determined by inductively coupled plasma – atomic 
emission spectroscopy (ICP-AES), and displayed an LSPR peak at 820 nm. Increasing 
the time allowed for reduction of the platinum salt resulted in the growth of a larger 
platinum shell on the AuNR tips of ~2.4 nm thickness. This increased the length of the 
NRs to 28.8 ± 4.2 nm and the width of the NR tips to 9.3 ± 1.2 nm (AR = 4.2 ± 0.6). 
These thicker nanorods contained a mole ratio of 20% Pt and 80% Au (Pt20Au80NRs) and 
displayed a further redshift in the LSPR band to 879 nm (see Figure 5.1 and Figure 5.2 
and Table 5.1). The width at the middle of the NRs did not increase significantly with 
platinum deposition, while the tip width increased by ~1.5 – 2.5 nm (Table 5.1). 
Additionally, an energy-dispersive X-ray spectroscopy (EDX) elemental line scan 
analysis showed platinum at the NR edges (Figure 5.3), indicating that the platinum shell 
grew primarily on the tips of the AuNRs, which is in agreement with the growth reported 



























Figure 5.3 (A) HAADF-STEM image of a single Pt20Au80NR. (B) EDX line-scan 
analysis of the Pt20Au80NR along the line in A, showing the location of platinum 
primarily on the NR tips.  
 
 
To increase the stability and biocompatibility of the NRs and prevent cellular 
internalization, a 5000 MW methoxypoly(ethylene) glycol thiol (PEG) polymer was 
conjugated to passivate the NR surface through the formation of the well-characterized 
Au–S bond.
55
 Successful conjugation of PEG is evident in the slight red-shift (8–12 nm) 
of the LSPR bands to longer wavelengths (Figure 5.4) and in the decrease of the zeta 
potentials of the NR solutions after PEGlyation (Table 5.2). The stability of the NRs was 
confirmed by diluting the suspensions in cell culture media and incubating at 37°C. After 
24 h, the NR solutions were exposed to NIR laser irradiation for 5 min. The solutions 
were then centrifuged to remove the cell culture media and dispersed in deionized (DI) 
water. Vis–NIR spectra of the NRs showed no significant changes before or after 
incubation and laser treatment (Figure 5.5), confirming the stability of the NRs. 
 162 
 
Figure 5.4 Vis-NIR extinction spectra of (A) AuNRs, (B) Pt13Au87NRs, and (C) 
Pt20Au80NRs before and after PEG conjugation. The redshift in the longitudinal LSPR 
bands is indicative of successful conjugation. 
 
Table 5.2 Zeta potential of NR solutions before (left) and after (right) PEG conjugation. 
The decrease in zeta potential confirms successful conjugation of PEG to the nanorods 
surface. 
 zeta potential (mV)  zeta potential (mV) 
AuNRs 40.7 ± 1.9 PEG-AuNRs 5.1 ± 1.4 
Pt13Au87NRs 42.0 ± 1.6 PEG- Pt13Au87NRs 4.9 ± 0.8 
Pt20Au80NRs 42.6 ± 2.3 PEG- Pt20Au80NRs 5.7 ± 1.0 















































































































Figure 5.5 Vis–NIR spectra of (A) AuNRs, (B) Pt13Au87NRs, and (C) Pt20Au80NRs in 
cell culture medium show no significant changes before (solid lines) and after (dashed 
lines) 808 nm laser exposure (5 min), indicative of NR stability. Spectra are normalized 
to account for concentration differences due to evaporation of media during photothermal 
heating. 
 
The heating efficiency of the NRs was first compared to determine the effect of 
platinum coating on the AuNRs absorption properties. Suspensions of the NR solutions 
were diluted to maximum optical densities (ODs) of 0.5 in culture media to mimic the 
conditions during cellular experiments. The thermal response of the NR solutions during 
808 nm laser irradiation at ~5 W/cm
2
 was measured directly in the cell culture media. As 
shown in Figure 5.6, the NR suspensions exhibited rapid temperature increases, with all 
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three NR solutions exceeding 46°C, the temperature required to induce hyperthermia,
49
 
within 30 s of irradiation. Within 1 min, the AuNR solution reached ~ 52°C, while both 
PtAuNR solutions exceeded 55°C, although no statistically significant difference was 
observed (p > 0.1). Upon increasing the exposure time to 5 min, the thermal response of 
AuNRs was found to reach a maximum of 57 ± 4°C. The Pt20Au80NRs reached a 
maximum temperature of 64 ± 2°C, while the Pt13Au87NRs reached a temperature of 66 ± 
3°C. In comparison, the media without NRs showed a minimal thermal response, only 
reaching 37°C after 1 min and peaking at 39 ± 1°C. While all NR solutions displayed a 
strong thermal response, the differences in temperature were most likely due to the 
degree of overlap between the NRs LSPR bands and the NIR laser. The Pt13Au87NRs 
displayed the greatest overlap (> 98 %) between their LSPR band and the laser and 
accordingly had the strongest thermal response. However, the Pt20Au80NRs displayed a 
greater thermal response than the AuNRs despite having lower laser overlap (66 % vs 
90%), likely due to the difference in NR concentration. Deposition of Pt on the NR tips 
led to a broadening of the LSPR bands, decreasing the extinction coefficient of the 
PtAuNRs. Since the thermal response was measured using NR solutions with the same 
OD of 0.5, the concentration of Pt20Au80NRs and Pt13Au87NRs was greater than that of 
AuNRs due to their lower extinction coefficients (Table 5.1), also contributing to the 
observed difference in thermal response. 
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Figure 5.6 Temperature increase induced by PPT heating of NR solutions (OD = 0.5) 
upon exposure to 808 nm laser excitation. Pt13Au87NRs (blue) show the largest 
temperature increase to 58°C at 1 min (saturates at 65°C), followed by Pt20Au80NRs (red) 
at 56°C at 1 min (saturates at 63°C), and AuNRs (yellow) at 52°C at 1 min (saturates at 
55°C). Control media without NRs only heat to 37°C at 1 min before saturating at 
40.5°C. The temperature of all solutions was between 35 and 36°C before laser 
excitation. 
 
The enhanced thermal response of PtAuNRs, relative to the traditional AuNRs, 
suggests the potential of these NRs as excellent PPT agents. Accordingly, we used human 
oral squamous carcinoma (HSC3) cells to compare the efficacy of the PtAuNR in vitro 
PPT treatment to that of the AuNRs. First, we confirmed that no significant cellular 
internalization was observed for any of the NRs studied (Figure 5.7) to mimic typical in 
vivo conditions for passively targeted PEG-AuNRs. Then, cancer cells were treated with 
the various NR solutions diluted to an OD of 0.5 in cell culture media for 1 h prior to NIR 
laser exposure. After 1 min exposure, the cells treated with the NR solutions displayed 




































significant cell death, as shown in Figure 5.8. Interestingly, while no statistically 
significant difference in cell death was observed between the NR treated samples, the 
AuNR- and Pt13Au87NR-treated cells displayed slightly lower cell viabilities (~65%) than 
the Pt20Au80NR-treated cells (~69%) after 1 min laser exposure. Cells exposed to the 
laser but without NR treatment, or treated with the NR solutions but without laser 
exposure, all displayed greater than 97% cell viability. This confirms the biocompatibility 
of the NR solutions, which do not induce cell death without laser exposure, and that cell 
death is due to PPT heating of the NR solutions. However, these results do not directly 
correlate to the thermal response measured for the NR solutions. While the Pt13Au87NRs 
showed the greatest heating efficiency, followed by the Pt20Au80NRs and then the 
AuNRs, the Pt13Au87NRs and the AuNRs induced slightly greater cell death than the 
Pt20Au80NRs. The disagreement between these findings further indicates that ROS play a 
significant role in cell death during PPT treatment as thermal effects alone would not 




Figure 5.7 Cellular uptake of PEG conjugated NRs by HSC3 cells following 2 h of 
incubation, shown as the percentage of NR treatment solution internalized ± standard 




Figure 5.8 Cell viability for HSC3 cells treated with different NR solutions (OD = 0.5) 
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The role of ROS during PPT was then investigated using a fluorescent 2,7-
dichlorofluorescein (DCF) assay to measure the reactive oxygen levels in cell culture 
media before and after treatment. For the DCF assay, we first synthesized the DCF from 
2,7-dichlorofluorescin diacetate (DCFDA), a common ROS probe. The DCFDA was 
deacetylated under basic conditions to yield the nonfluorescent dichlorofluorescin 
(H2DCF). The H2DCF was then used to measure ROS as it was readily oxidized into the 
highly fluorescent DCF compound, which showed an excitation maximum at 495 nm and 
an emission maximum at ~525 nm (Figure 5.9). 
 
Figure 5.9 Excitation and emission spectra of 67 μM solution of 2,7 –
Dichlorofluorescein (DCF) in phosphate buffered saline (PBS, pH = 7.4). 
 





























To investigate the ROS produced during PPT treatment, we again treated cancer 
cells with the solutions of the NRs in culture media. After 1 h of incubation, the cells 
were exposed to the NIR laser to induce hyperthermia and then incubated with the NR 
solutions for an additional 30 min to allow for the generation and potential reduction of 
ROS. Finally, the DCF assay was used to measure the amount of ROS present in the cell 
media before and after laser exposure. As shown in Figure 5.10 and Figure 5.11, 
incubation of the cells with AuNRs or Pt13Au87NRs did not alter the amount of 
endogenous ROS present in the media before laser exposure. However, incubation with 
Pt20Au80NRs without laser exposure led to a highly significant (p < 0.01) reduction in 
ROS levels from the untreated control. While this demonstrates the successful ROS 
scavenging ability of the Pt20Au80NRs, prolonged exposure to these NRs has the potential 
to perturb normal cellular function as endogenous ROS serve an important role in many 
redox-based signaling pathways.
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 After laser exposure, the amount of ROS in culture 
media containing AuNRs displayed a highly significant increase in fluorescence, 
confirming the formation of ROS during PPT treatment. However, media without NRs or 
with PtAuNRs did not show any significant changes in fluorescence after laser exposure, 
indicating that the ROS formed during PPT treatment were reduced by the Pt shell on the 
AuNRs. The control cells, incubated with media without NRs, did not display a 
significant thermal response (Figure 5.6), so heat-stress induced ROS likely are not 
formed during PPT treatment and fluorescence is only detected from endogenous ROS. 
Additionally, the amount of ROS present in Pt20Au80NRs containing cell media was again 
lower than the control samples but did not change after laser exposure. These results 
again confirm the ROS scavenging ability of the PtAuNRs while accounting for the 
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discrepancy between the thermal response of the NRs and the cell viability assay. While 
AuNRs displayed the weakest thermal response to PPT treatment, significant amounts of 
ROS were produced during the treatment, likely resulting in some chemically induced 
cell death, through oxidative damage, in addition to the hyperthermia-induced toxicity. 
Accordingly, although the PtAuNRs displayed the strongest thermal response to PPT, 
they also reduced any ROS produced during the treatment before oxidative damage could 




Figure 5.10 Levels of ROS in cell media before (0 min) and after (1 min) PPT heating. 
Before heating, Pt20Au80NRs show less ROS due to reduction of endogenous oxygen by 
Pt. After heating, AuNR-treated cells show significantly higher ROS levels due to heat 
stress. PtAuNRs do not show significant increases in ROS levels, indicating that the 
reactive species are reduced before cell damage can occur. Statistical significance (p < 
0.05) is indicated by an asterisk. 
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Figure 5.11 Example emission spectra of ROS present in cell culture medium containing 
NR solutions before (A) and after (B) laser exposure. Control samples (no NR), 
Pt13Au87NRs , and Pt20Au80NRs containing medium do not show significant changes in 
ROS levels before or after laser exposure, although incubation with Pt20Au80NRs reduces 
the level of endogenous ROS in both cases. AuNR containing medium shows no 
difference in ROS from endogenous levels before laser exposure, but shows a significant 
increase in ROS levels after exposure. 
 
We then extended our study to determine the toxicity of the ROS produced during 
PPT treatment on healthy, untreated human keratinocyte (HaCat) cells. Cancer cells were 
again incubated with the NR solutions and exposed to the NIR laser to induce 
hyperthermia through PPT treatment. After laser exposure and incubation, the medium 
was aspirated and the NRs were removed through centrifugation. The laser-treated 
medium was then added to the HaCat cells and incubated for 24 h to determine the 
toxicity of the solutions after PPT treatment. Cells treated with fresh medium, without 
any exposure to the laser or cancer cells, were used as a control to normalize cell viability 
values. The healthy cells that were incubated with laser-treated media that previously 
contained PtAuNRs or did not contain any NRs but underwent NIR exposure showed no 
significant changes in cell viability (p > 0.86). However, the healthy cells incubated with 


























































































laser-treated media that had previously contained AuNRs did show a statistically 
significant decrease in viability (p = 0.0036), as seen in Figure 5.12.  The toxicity of the 
laser-treated AuNR solution on healthy, untreated cells further supports the conclusion 
that ROS play a significant role during PPT treatment. Because of the similar thermal 
responses between the AuNRs and the PtAuNRs (Figure 5.6), comparable heat stress-
induced ROS production, and accordingly cell death, would be expected between the NR 
treatments. However, the lack of cell death from the PtAuNR-treated samples further 
confirms the effective scavenging of ROS by the platinum shell. 
 
 
Figure 5.12 Viability of HaCat cells incubated with media from laser-treated HSC3 
cancer cells. Cell media following AuNR PPT heating caused statistically significant (p = 
0.0036, indicated by an asterisk) cell death, indicating the presence of harmful ROS 
remaining in solution. Solutions without NRs or with Pt-coated NRs show no significant 
decrease in cell viability (p > 0.86), indicating that ROS are reduced, mitigating side 



































We have shown the utility of PtAuNRs as efficient PPT agents that induce cell 
death through hyperthermia while scavenging the ROS produced during treatment. The 
optical properties of the NRs could be tuned by adjusting the thickness of the Pt shell on 
the NR tips and are not affected by interactions with complex cell culture media or during 
NIR laser exposure, confirming their stability. The Pt coating does not impair the thermal 
response of the NRs to laser exposure but instead enhances it slightly. The NR solutions 
do not induce cell death alone, confirming their biocompatibility, and induce cell death 
upon laser exposure, verifying their usefulness as PPT agents. The ROS scavenging 
ability of the PtAuNRs is also demonstrated through the fluorescent assays used to 
measure the reactive oxygen present in the NR solutions before and after PPT treatment. 
Laser exposure of AuNRs is shown to produce significant amounts of ROS, which have 
the potential to react with healthy tissue causing unwanted side effects and contribute to 
toxicity. PPT treatment of the AuNRs results in cell death through both hyperthermia and 
the formation of ROS, resulting in toxicity toward healthy, untreated cells. In contrast, the 
PPT treatment of PtAuNRs induces cell death solely through hyperthermia and no 
detectable changes are observed in ROS levels after laser exposure. The Pt13Au87NRs are 
the most promising nanoparticle studied for PPT treatment as they do not alter 
endogenous ROS levels and efficiently induce cell death through hyperthermia while 
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